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AIS      Axon Initial Segment 
bp     base pairs 
CAP     compound action potential 
CAM     Cell-adhesion molecule 
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CNS     Central nervous system 
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d     days 
DIV     Days in vitro 
DTT     Dithiothreitol 
EDTA     Ethylene diamine tetracetic acid 
ES     Embryonic day  
FITC     Fluorescein isothiocyanate 
h     hour 
HCl     Hydrochloric acid 
HRP     Horseradish peroxidase 
Ig     Immunoglobulin 
kb     kilobases 
kD     kiloDalton  
Kv     Voltage-gated potassium channels 
K
+     
potassium ion 
LB     Luria-Bertani medium 
mA     milli-ampere 
MAG     Myelin associated glycoprotein 
MBP     Myelin Basic Protein 
min     minutes 
mm     millimeter 
mM     millimolar 
mRNA     messenger RNA 
MS     Multiple sclerosis 
Na
+     
sodium ion 
Nav     Voltage-gated sodium channels 
NF     Neurofilament 
Nfasc     Neurofascin 
ng     nanogram 
NTZ     and nuclear transitory zone  
OCT     Optimal cutting temperature 
OSP     Oligodendrocyte specific protein 
P     Post-natal day 
P0     Myelin protein zero 
PAGE     Polyacrylamide gel electrophoresis 
PB     Phosphate buffer 
PBS     Phosphate buffer saline 
PC     Purkinje cell 
PCR     Polymerase chain reaction 




PLP     Proteolipid protein 
PMSF     Phenylmethanesulphonylfluoride 
PNS     Peripheral Nervous System 
RLS     rhombic lip migratory stream 
s     seconds 
SC     Schwann cell 
SDS     Sodium dodecyl sulfate 
TAE     Tris-acetate-EDTA 
TESPA    3’Amino propyl tri ethoxy silane 
TRIS     trishydroxymethylaminomethane 
TRITC     Tetramethylrhodamine isothiocyanate 
µm     micron 
µl     microliter 







The nodes of Ranvier are short, periodical interruptions in the myelin sheath of 
myelinated axons, at which voltage-gated sodium channels are highly concentrated. 
The correct targeting of sodium channels to the nodes of Ranvier permits rapid 
propagation of action potentials in myelinated axons. The nodes of Ranvier contain a 
unique set of ion channels, cell-adhesion molecules, and cytoplasmic adaptor 
proteins.  
 
Neurofascins are cell adhesion molecules of the immunoglobulin superfamily and 
previous work has shown they are involved in the assembly of the node of Ranvier. 
The Neurofascin (Nfasc) gene is subject to extensive alternative splicing. RT-PCR 
studies have suggested that there were several different Neurofascin (Nfasc) 
transcripts. Thus far, research on the Neurofascins has concentrated on two isoforms, 
Nfasc186 and Nfasc155, which are expressed in neurons and glia respectively. A 
third Neurofascin isoform, Nfasc140, lacking the Mucin domain and two of the 
fibronectin repeats was originally identified in the laboratory of V. Bennett. However, 
neither the location nor function of this protein was known. 
 
By RT-PCR I successfully cloned the Nfasc140 cDNA and determined its domain 
composition, which was confirmed by a series of Western blots using domain-specific 
antibodies. The developmental expression of Nfasc140 revealed that it is the 
predominate isoform of Neurofascin during the embryonic stage. Using cell-type-
specific conditional Neurofascin knock-out mice, I have also found that Nfasc140 is a 
neuronal isoform, like Nfasc186.  
 
I have used transgenic mouse lines to characterize the location and function of 
Nfasc140. Like Nfasc186, Nfasc140 is targeted to the nodes of Ranvier and axonal 
initial segment. Also Nfasc140 alone can reconstitute the nodal complex in 
Neurofascin knock-out mice in CNS and PNS in the absence of Nfasc186 and 
Nfasc155. It can also partially restore the electrophysiological function of PNS nerves. 
 
In order to address the role of the paranodes in sodium channel clustering, I 
generated a new neuronal-Cre-expressing transgenic line which, when bred with 
floxed Nfasc mice, generated early neuronal Neurofascin knock-out mice. Using 




only glial Nfasc155 is presented, sodium channels can still target to the nodes of 
Ranvier in both PNS and CNS. These conditional knock-out mice have a longer life 
span than pan-Neurofascin knock-out mice. This indicates the importance of 
paranodal junctions, in addition to nodal neuronal Neurofascins, in clustering sodium 
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1.1 Myelin and Nodes of Ranvier. 
The myelin sheath is a greatly extended and modified plasma membrane of glial cells 
wrapped around the nerve axon (Raine et al., 1984). The non-conductive lipid-rich 
myelin sheath coats and thus provides insulation for the most part of the axonal 
surface, increasing electrical resistance and decreasing capacitance between the 
inside and outside of a nerve fibre (Hartline and Colman, 2007). Nodes of Ranvier 
are short and periodical interruptions of the myelin sheath, (Morell et al., 1999). 
Myelin sheaths are formed by two different glial cells: Schwann cells in the 
vertebrate peripheral nervous system (PNS), named after the German physiologist 
Theodor Schwann; their counterparts in the central nervous system (CNS) are the 
oligodendrocytes, first described as mesoglia by William Ford Robertson, an 
Edinburgh pathologist Dr W.F. Robertson in 1899 (Robertson, 1900). Myelination is 
found mainly in vertebrates, but an analogous system has been discovered in a few 
invertebrates, for example in members of the Annelida, Arthropoda and Chordata 
(Roots, 2009). Not all neurons in vertebrates are myelinated; for example, axons of 
the neurons comprising the autonomous nervous system are not, in general, 
myelinated (Simons et al., 2007). Nodes of Ranvier are regularly spaced along the 
length of myelinated nerve fibres, and enable saltatory conduction in which action 
potentials appear to “jump” from node to node. Myelin and nodes of Ranvier have 
allowed the development of complex nervous systems with rapid impulse 
propagation resulting in, among other things, more rapid and sustained responses in a 
predator-and-prey environment (Hartline and Colman, 2007; Nave et al., 2010).  
 
1.2 Electrophysiology of axon  
1.2.1 Ion Channels and action potential  
The  action potential (Fig. 1) is a short-lasting event in which the electrical 
transmembrane potential rapidly rises and falls, following a consistent trajectory. 




(1939). Along the axon a voltage difference between the interior and the exterior of 
the cell, known as the membrane potential (resting), is established and maintained by 
sodium-potassium ATP-dependent pumps. The ATP-dependent pumps concentrate 
Na
+
 outside and K
+
 inside. Nav channels possess a sensor mechanism that detects 
depolarization in transmembrane voltage. Synaptic inputs to a neuron triggering this 
sensor and promote Nav opening, and Na
+ 
flow inward causing membrane 
depolarization. When membrane depolarization reaches the threshold, a rapid 
recruitment of Nav leads to the fast depolarizing phase of the action potential. The 
same raised voltage also causes the sodium channels to become inactivated. At the 
same time, the raised voltage opens Kv, and K
+ 
flowing out leads to repolarization. 




 permeability cause the membrane potential 
to drop quickly back towards to the resting state (Hodgkin & Huxley,1939, Neher et 
al., 1976, Barnett et al., 2007). 
 
Figure 1. Schematic picture of an idealized action potential (reproduced 
picture from http://mcat-review.org) 
The picture shows the various phases as the action potential passes a point on 
a cell membrane. Which includes  
1. Resting: cell at rest, sodium-potassium pump maintaining resting 
potential. 
2. Depolarization: sodium channels open, positive sodium rushes inside, 
membrane potential shoots up. 
3. Repolarization: potassium channels open, sodium channels close, 
positive potassium rushes outside, membrane potential drops back 
down.  
4. Hyperpolarization: potassium channels doesn't close fast enough, so 





5. Refractory period: the sodium-potassium pump works to re-establish 
the original resting state . 
1.2.2 Electrophysiology of axon 
Nerve conduction velocity depends critically on axon diameter and myelination.  
Larger diameter axons have a greater total volume for charges to flow through with 
correspondingly less resistance from the membrane (Arbuthnott et al., 1980).In 
unmyelinated axons, studies also suggest that conduction velocity can be mediated in 
other ways. For moderate discharge rates, the conduction speed is determined by the 
dynamic equilibrium between the slowing effect of cumulative sodium channel 





(Rang & Ritchie, 1968, Gordon et al. 1990, Morita et al. 1993, Kobayashi et al. 1997, 
De Col et al., 2008). 
 
In myelinated axons the conduction velocity is affected by the myelin sheath. The 
myelin sheath wraps around the axon to form a high resistance insulating membrane. 
Thus, the local currents are unable to leak across the membrane because of the 
insulating myelin, resulting in their greater penetration down the core of the axon. 
Action potentials cannot propagate through the membrane in myelinated segments of 
the axon. However, the current is carried by the axonal cytoplasm, which is sufficient 
to depolarize the first or second subsequent node of Ranvier. Myelination and the 
high densities of Nav at the nodes of Ranvier, allow the action potential to propagate 
by jumping from node to node by what is called “saltatory conduction” (Huxley et al., 
1949, Barnett et al., 2007,). By saltatory conduction the myelinated axon has the 
ability to increase the speed of conduction, and also nodal conduction results in 
significant economies of energy and space (Salzer et al., 1997). 
 
1.3 Structure and functions of myelinated axons  
1.3.1 Four regions of myelinated axons. 
Based on morphology and protein composition, myelinated axons can be divided into 




microvillar processes arising from the outer collar of the Schwann cells in the PNS or 
by perinodal extensions from astrocytes in the CNS (Butt et al., 1994). The nodes are 
enriched in voltage-gated sodium channels (Nav), a density of 25-fold of that along 
the internode, providing a site for the generation of the action potential (Hille, 2001). 
Ezrin, radixin and moesin (ERM) belong to a family of actin-binding proteins. In the 
PNS, the microvilli, which are enriched in ERM, express a unique perinodal matrix 
thought to be important in node formation and function (Scherer et al., 2011, 
Melendez-Vasquez et al., 2001, Salzer et al., 2008). In both PNS and CNS, the 
interaction of nodes of Ranvier with extracellular matrix is crucial for axon 
formation and myelination (Colognato et al. 2005; Chernousov et al. 2008). 
Gliomedin is a protein in the ECM, knockdown of Gliomedin can cause the 
mislocolization of new channels (Feinberg et al., 2011). And also Brevican as a 
member of ECM in CNS may have a role in regulating the extracellular matrix 
(Bekku et al., 2009).  
 
 
Figure 2. Organization of myelinated PNS fibers (Salzer et al., 2008). 
Schematic picture showing the four different regions of a myelinated fibre. 
Node in the center labelled in blue, flanked by paranodal junctions labelled in 
green. Juxataparanodes are in purple next to paranodal junctions. And 
Internodes are in red which are a continuation of the Juxataparanode. The size 
of the node spans from 1–2 µm whereas the internodes can be up to (and 





The paranodal axoglial junctions (Fig. 2 green) flank either side of the node. The 
junctions are the site of closest apposition between the myelinating cell and the 
axonal membranes. In longitudinal sections, a series of loops formed by the glial 
cells are closely lined around the axolemma; a series of transverse bands can be 
observed at the axoglial junctions (Peters et al., 1991). Paranodal junctions serve as a 
diffusion barrier between the nodal area and the juxtaparanodal regions (Fig. 2 
purple). Mouse mutants which have defects in the paranodal junctions show 
relocalization of Kv1.1 and Kv1.2 channels towards the paranodal region and the 
diffusion of Nav channels (Pillai et al., 2009, Rios et al., 2003,  Bhat et al., 2011).  
 
The juxtaparanodal regions (Fig. 2 purple), on the outer side of the paranodal 
junctions, are enriched in hetero-multimers composed of Kv1.1, Kv1.2, and their 
cytoplasmic Kv2 subunit, which may stabilize conduction and help to maintain the 
internodal resting potential and repolarize the membrane during an action potential; 
but the precise function of Kv channels remains unclear (Wang et al., 1993, Rhodes 
et al., 1997, Rasband et al., 1998, Zhou et al., 1998, Vabnick et al., 1999). 
 
The segments between nodes of Ranvier are termed internodes (Fig. 2 red), and their 
outermost parts are in contact with the juxtaparanodal regions (Fig. 2 purple). They 
are the longest regions of the myelinated fibres and have a low capacitance and high 
transverse resistance. Compared with the high capacitive load in unmyelinated axons 
or poorly myelinated internodes, myelinated internodes can enhance the ability of the 
inward current at one node to depolarize the next nodal membrane without wasting 
charge and time on discharging the transmembrane capacitance (William et al., 2002). 
 
1.3.2 Protein organization of nodes of Ranvier 
To perform their function, nodes of Ranvier are composed of a unique set of 
molecules.  
 
By immunofluorescent studies, various proteins have been identified at the nodes 




NrCAM and Nfasc186, ion channels Nav and Kv3.1b and membrane skeleton protein 
ßIV Spectrin. Also other proteins have been found expressed at the nodal area (Fig. 
3A), which include ezrin–radixin–moesin proteins, dystroglycan, proteoglycans, 
brain link protein 1 and tenascin-R. AnkyrinG is likely to have a very important 
linking role through possible interaction with other nodal proteins. 
Immunoprecipitation showed the interaction between Nav and AnkyrinG which 
suggested Nav channels are anchored to AnkyrinG. Mislocalization of Nfasc186, 
NrCAM was found in AnkyrinG knockout mice and AnkyrinG and Kv3.1b have been 
co-immunoprecipitated (Srinivasan et al., 1988, Xu et al., 2007, Zhou et al., 1998). 
This suggests that all four proteins interact with AnkyrinG. AnkyrinG is missing in 
ßIV-Spectrin knockout mice indicating that AnkyrinG is connected to the 
cytoskeleton through ßIV-Spectrin (Komada et al., 2002). In vitro, all three ezrin–
radixin–moesin proteins are expressed predominantly in Schwann cells, notably in 
their microvilli.  
 
In the PNS, Schwann cell microvilli encapsulate the nodal gap. The ezrin–radixin–
moesin proteins are concentrated in the nodal processes of cultured myelinating 
Schwann cells (Melendez-Vasquez et al., 2001). These data suggested ezrin–radixin–
moesin were expressed by Schwann cell microvilli. Dystroglycan was expressed by 
cultured Schwann cells where it localizes to the outer membrane apposing the basal 
lamina. Selective deletion of Schwann cell dystroglycan resulted in slowed nerve 
conduction and nodal changes including reduced sodium channel density and 
disorganized microvilli (Saito et al., 1999, Saito et al., 2003).  
 
In the CNS extensions from astrocytes and a specialized extracellular matrix (ECM) 
surround the nodes. In vitro protein expression studies and in vivo 
immunofluorescent studies, have suggested that the ECM is composed of three 
chondroitin sulfate proteoglycans (Brevican, phosphacan, and versican V2) (Bartsch 
et al., 1993, Xiao et al.,1997, Oohashi et al., 2002, Hedstrom et al., 2007). However, 





At the paranodes (Fig. 3B), the proteins which have been identified by 
immunofluorescence are Nfasc155, Caspr and Contactin. Their detailed interactions 
will be explained at section 1.5.1. At the paranodes, Caspr/Contactin from the 
axolemma together with Nfasc155 from the glial membrane form the Nfasc155-
Caspr-Contactin complex (Tait et al., 2000, Zonta etal., 2008). GST-pull down 
assays and immunoprecipitations showed the cytoplasmic tail of Caspr interacts with 
the cytoskeletal adaptor protein 4.1B (Denisenko-Nehrbas et al., 2003), providing a 
potential link with the actin cytoskeleton. 
 
At the juxtaparanodal reign (Fig. 3C) the proteins which have been identified by 
immunofluorescence are Kv channels, Caspr2 protein 4.1B, PSD95, Tag1 and 
Connexin 29. 
 
It has been shown Caspr2 binds to the N-terminal FERM domain of protein 4.1R and 
B through the GNP motif. Protein 4.1B clusters at paranodes and juxtaparanodes 
during postnatal development. Finally, Caspr2 coimmunoprecipitated with 4.1B from 
rat brain homogenates. These results suggest that protein 4.1B is associated with 
Caspr2 at juxtaparanodes, and may constitute a potential link between the paranodal 
and juxta-paranodal axolemma and the axonal cytoskeleton (Denisenko-Nehrbas et 
al., 2003). PSD-95 colocalizes precisely with Kv1 potassium channels and Caspr2 at 
juxtaparanodes, and a macromolecular complex of Kv1 channels and PSD-95 can be 
immunopurified from mammalian brain and spinal cord. The high density clustering 
of Kv1 channels and Caspr2 at juxtaparanodes is normal in a mutant mouse lacking 
juxtaparanodal PSD-95, suggesting that the indirect interaction between Kv1 
channels and Caspr2 is maintained in these mutant mice. These data suggested that 
the primary function of PSD-95 at juxtaparanodes lies outside of its accepted role in 
mediating the high density clustering of Kv1 potassium channels at these sites 
(Rasband et al., 2002). In unmyelinated fibers, TAG-1 was still expressed by 
ensheathing Schwann cells; in mature myelinated fibers of the CNS and PNS, TAG-1 
is localized to the juxtaparanodal region, which colocalized with Kv (Traka et al., 
2002). Immunofluorescence showed Connexin 29, which localizes at the glial 







Figure 3. Schematic representation of the molecular organization of the nodal 
and perinodal regions of a PNS myelinated fiber. (Pictures modified from 
Poliak et al., 2003). 
A. Nodal region in PNS and proteins which are targeted to nodal region. 
Microvilli of Schwann cells or perinodal astrocytes surround the nodes.  
B. Paranodal region in PNS and protein compositions at the paranodes. The 
paranodal loops from Schwann cells wrap around paranodes.  
C. Juxtaparanodal region in PNS and the protein composition at the 








1.4.1 Neurofascin gene and isoforms 
The Neurofascin gene (Nfasc) encodes cell adhesion molecules (CAMs) of the 
immunoglobulin superfamily (Ig-CAMs) that can initiate and maintain the 
organization of the node of Ranvier. Neurofascins were initially discovered in chick 
as cell surface molecules involved in the promotion of neurite extension (Rathjen et 
al., 1987). Meanwhile, the group of Bennett found binding partners of AnkyrinG and 
identified high molecular mass transmembrane proteins in the nervous system termed 
ankyrin-binding glycoprotein (ABGP), which are now referred to as Neurofascins 
(Davis et al., 1993). Neurofascin was also identified in zebrafish (Voas et al., 2009). 
Thus, Neurofascins are widely expressed in different species.  
 
In the mouse, the Neurofascin gene is composed of 34 exons distributed over 72 
kilobases (Hassel et al., 1997). Each of the six immunoglobulin (IgG1-6) and five 
fibronectin type III (FnIIIA-E) domains is encoded by two exons. Neurofascins can 
also contain a Mucin domain (M). They all contain a single transmembrane region 
(Tm) and a cytoplasmic domain (IC) (Fig. 4A). PCR analyses showed that Nfasc 
mRNA can undergo extensive mRNA splicing. In mouse, three isoforms of 
Neurofascin were identified by western blot. They were Nfasc186, Nfasc155 and 
Nfasc140 (Davis et al., 1993) (Fig. 4B). However, only the domain compositions of 
Nfasc186 and Nfasc155 were reported (Tait et al., 2000) (Fig. 4A). Also the related 
NH2-terminal sequences of Nfasc186, Nfasc155 and Nfasc140 indicated that they are 
alternatively spliced products of the same pre-mRNA (Davis et al., 1993) (Fig. 4B). 
Previous studies had suggested that Nfasc186 has a function in the maintenance of 
the protein complex structures of axo-axonic interactions but recent studies have 
focused on its role in the assembly of nodes and the stabilization of the protein 
components of the Axon Initial Segment (AIS) (Hassel et al., 1997, Sherman et al., 





Figure 4. Different isoforms of Neurofascins in mouse (Fig. 4A is modified 
from Tait et al., 2000; Fig. 4B is from Davis et al., 1993).  
A. Only the domain compositions of Nfasc186 and Nfasc155 were identified in 
rodents. Nfasc155 has a specific FnIIIC domain, Nfasc186 has Mucin and 
FnIIIE domains (Tait et al., 2000). The domain compositon of Nfasc140 has 
not been studied in the past. 
B. Western blot showing the mobility of Nfasc186, Nfasc155 and Nfasc140 
from rat tissue extractions (Davis et al., 1993). Their N-terminal sequences 
confirmed they are all Neurofascins. 
 
Neurofascin has also been identified in chick and studies on chick suggested more 
isoforms of Neurofascin could be present in animal tissue. One study has suggested 
that there could be more than 50 different Neurofascin transcripts (Hassel et al., 
1997). This could result in many different isoforms of Neurofascin proteins. 
However, the proteins which have been identified so far by antibodies are not so 
diverse. There are four different isoforms of Neurofascin proteins found in chick, 
Nfasc186, Nfasc180, Nfasc155 and Nfasc166 (Fig. 5) (Hassel et al., 1997, Martin et 





Figure 5. Different isoforms of Neurofascins in chick (Picture modified from 
Hassel et al., 1997).  
A. Schematic representation of the four different isoforms of Neurofascins 
found in chick. Nfasc155 has specific FnIIIC domain. Nfasc166 does not have 
unique domains. Nfasc180 has a Mucin domain and is only found in chick. 
Nfasc186 has the Mucin and FnIIIE domains.  
B. Western blot demonstrating the different mobility of those 4 isoforms of 
Neurofascins. 
 
1.4.2 Role of Nfasc186 and Nfasc155 in clustering Nav channels.  
A key observation concerning the function of the Neurofascins was the 
demonstration that in the Neurofascin knockout (Nfasc
-/-
) mouse Nav channels are no 






small proportion (16%) of nodes have clustered Nav channels in CNS in the absence 
of the Neurofascins (Sherman et al., 2005, Zonta et al., 2008).  
 
Both in vitro and in vivo studies have supported the view that neuronal Nfasc186 has 
a role in clustering Nav channels at the nodes of Ranvier. In vitro, short hairpin RNA 
(shRNA) knockdown of Nfasc186 in DRG and Schwann cell co-culture showed Nav 
channels fail to cluster at the nodes of Ranvier in PNS (Dzhashiashvili et al., 2007). 
Meanwhile, the in vivo study of Zonta showed when Nfasc186 is expressed in 
neurons on a Neurofascin knockout mouse background, it is sufficient to restore the 
Nav channels in the nodes in PNS (Zonta et al., 2008). Meanwhile, in the CNS, 
expression of Nfasc186 showed that Nav channel-positive nodes were restored from 
less than 20% in knockout mice to more than 90% in transgenic mice expressing 
only Nfasc186 (Zonta et al., 2008). In another animal model, in which Nfasc155 was 
deleted, where only Nfasc186 was present, Nav channels were able to be targeted at 
the nodes in the PNS supporting the earlier data (Thaxton et al., 2012). From the 
above observations it is clear that Nfasc186 alone can restore the Nav channels at the 
nodes in both PNS and CNS. 
 
On the other hand, the role of Nfasc155 in clustering of nodes has been controversial, 
and different researchers have come to different conclusions. In vivo, in the PNS, 
Nfasc155 lacking its C-terminus was unable to rescue sodium channel clustering in 
the absence of Nfasc186 whereas in the CNS it was (Sherman et al., 2005, Zonta et 
al., 2008). In vitro, shRNA knockdown of Nfasc186 in DRG co-culture, which still 
has glial Nfasc155 showed no sodium clustering (Dzhashiashvili et al., 2007). Which 
suggested Nfasc155 alone is not sufficient to restore the Nav channels. Meanwhile, 
an in vivo study of Thaxton, after conditional knockout of Nfasc186, suggested that 
Nfasc155 alone can not restore Nav channels clustering at the nodes of Ranvier both 
in the CNS and PNS (Thaxton et al., 2012). This contradicted the findings of Zonta, 
at least in the CNS (Zonta et al., 2008). Moreover, a paper of Feinberg et al showed 
that when Nfasc155 is expressed in Schwann cell-neuron co-culture, sodium 




The possible cause of the differences is further discussed in the chapter of 
conclusions and discussion 4.3.3. 
 
1.4.3 Other functions of the Neurofascins. 
The Nfasc155–Caspr–Contactin complex promotes oligodendrocyte process 
migration. 
In the CNS, before myelin formation, oligodendrocytes extend processes along axons; 
and the process of each oligodendrocyte migrates to eventually form nodes of 
Ranvier. Oligodendrocyte process migration is an early critical step for myelination. 
In teased spinal cords where oligodendrocytes do not express Nfasc155, there is a 
delay in process migration, which is restored to be similar to WT when Nfasc155 is 
re-expressed on a Neurofascin-null background (Zonta et al., 2008). This indicates 
that Nfasc155 and the adhesion complex promotes the migration of oligodendrocyte 
processes in the CNS. 
 
Regulation of Neurite outgrowth 
Neurites are undifferentiated axons or dendrites extended by cultured neurons and 
neurite outgrowth is likely to be a key process during neuronal migration and 
differentiation. In vitro, a Neurofascin-Fc chimera protein increases the neurite 
outgrowth of cultured tectal neurons from chick (Volkmer et al., 1996). An 
experiment on mouse reaggregated cerebellar cells showed that Nfasc186-Fc 
depresses neurite outgrowth but Nfasc155-Fc promotes neurite outgrowth (Koticha et 
al., 2005). In another chick Dorsal Root Ganglion (DRG) culture study, Nfasc166, 
which is an early isoform in chick, is required for neurite outgrowth and Nfasc186 
depresses the outgrowth (Pruss et al., 2006). Further in vitro study has shown that 
Nfasc166 can interact with fibroblast growth factor receptor 1 (FGFR1) through both 
extra- and intracellular domains. But only the intracellular domains are necessary and 
sufficient to active the FGFR1 domain, which promotes neurite outgrowth 
(Kirschbaum et al., 2009). Neural CAM (NCAM), a cell surface glycoprotein whose 




repeats functionally interacts with FGFR (Hinsby et al., 2004). Although Nfasc166 
and NCAM have very similar extracellular domain compositions, the intracellular 
domain of Nfasc166 which interacts with FGFR1 is different from NCAM. There is 
no study on Nfasc166 mediated FGFR-dependent biochemical events, so it is unclear 
whether Nfasc166 can regulate FGFR with the same mechanism as NCAM. 
 
Nfasc186 is essential for AIS stabilization  
The axon initial segment (AIS) is the unmyelinated proximal part of an axon close to 
the cell body. Recent experiments suggest that the composition and topographical 
organization of the initial segment is dynamically and precisely organized (Colbert et 
al., 2002, Kole et al., 2008, Hu et al., 2009, Fleidervish et al., 2010, Grubb et al., 
2010,  Kuba et al., 2010). Like nodes of Ranvier, the AIS has a high concentration of 
Nav channels which are believed to be the cause of the low threshold for initiation of 
action potentials at the AIS. AnkyrinG promotes clustering of Nav channels at the 
AIS (Hedstrom et al., 2008, Zhou et al., 1998). Other proteins also found at the node 
include Kv channels (Clark et al., 2009), the scaffolding protein βIV-Spectrin and the 
cell-adhesion molecules Nfasc186 and neuron-glia related cell-adhesion molecule 
(NrCAM) (Rasband et al., 2010). Through a FIGQY motif in its cytoplasmic domain, 
Nfasc186 is able to bind to AnkyrinG and localize at the AIS (Davis et al., 1994, 
Dzhashiashvili et al., 2007, Lemaillet et al., 2003). 
 
Different from nodes of Ranvier, the clustering of Nav channels at the AIS seems to 
be independent of Neurofascins. An in vitro study showed, after shRNA knockdown 
of Nfasc186 in cultured hippocampal neurons, only NrCAM and Brevican were 
affected, all other components including Nav channels were still targeted to the AIS 
(Hedstrom et al., 2007). Meanwhile, in Neurofascin knockout mice, when Nfasc186 
is not expressed, NrCAM is mislocalized but other AIS proteins can target to the AIS 
without Neurofascins (Zonta et al., 2011). These results suggested that Nfasc186 is 
not involved in the targeting of sodium channels to the AIS.  
 
However, although it is not required for AIS assembly, Nfasc186 is essential for AIS 




mice leads to the loss of key components of AIS including Nav channels. Purkinje 
cells with a disrupted AIS, but intact nodes of Ranvier, are no longer able to fire 
spontaneous action potentials. Interestingly, following stimulation those Purkinje 
cells are still able to generate evoked action potentials but with significantly altered 
characteristics (Zonta et al., 2011). These mutants had an altered gait, and testing 
their motor coordination and balance using a rotarod revealed significant deficits in 
mutant animals compared to controls. And in the paper they stated the phenotype 
could not be attributed solely to disruption of Purkinje cell AIS function since many 
other neuronal cell types including spinal motor neurons were affected as well. 
 
1.4.4 Neurofascins in neurological diseases.  
Since Neurofascins are key components of nodes of Ranvier and AIS in the nervous 
system, the role of Neurofascins in neurological diseases has been explored in 
several studies recently. 
Autoantibodies of Neurofascins in diseases 
Assays to detect antibodies against human Nfasc155 and Nfasc186, and showed that 
autoantibodies to Neurofascins are found in 4% of patients with chronic 
inflammatory demyelinating polyneuropathy (CIDP) and acute inflammatory 
demyelinating polyneuropathy (AIDP) (Ng et al., 2012). In this study only 4% of 
patients had antibodies against Neurofascins; the large number of patients who did 
not have them suggest that the Neurofascins are unlikely to be important primary 
target autoantigens (Hughes et al., 2012). 
 
However, those studies only detected the antibodies at one time point, there were no 
follow-up studies to explain the antibodies’ appearance during the development of 
the disease and disappearance with treatment or recovery, so there is no way to 
determine if Neurofascin antibodies are a cause or effect of the diseases (Hughes et 
al., 2012).  
 
The serum reactivities observed were against only one of the two isoforms of 




Nfasc186 are very similar, with the difference being only in the 2 domains closest to 
the transmembrane region (Sherman et al,. 2005, Hughes et al., 2012). By expressing 
truncated variants of Nfasc155 and Nfasc186, the FnIIIC (which were referred to as 
fibronectin type III repeats 3-4 in the original paper) domain was identified as the 
target for Nfasc155-specific reactivity and Mucin and FnIIIE domains for Nfasc186 
specificity (Hughes et al., 2012). 
 
Hence, the role in pathogenicity of these antibodies is still unclear. In previous 
observations the presence of antibodies to Nfasc186 in the presence of complement 
disrupted nerve conduction and antibodies to Nfasc155 inhibit myelination by 
blocking the formation of the Caspr/Contactin/Nfasc155 complex (Mathey et al., 
2007, Charles et al., 2002), they suggested similar phenomena could occur in human 
patients (Hughes et al., 2012). But no experiment was conducted to examine their 
theories. 
 
 Neurofascins in MS 
Multiple sclerosis is characterized by perivascular inflammation, myelin and 
oligodendrocyte damage, axonal loss and astrocytic scarring. Nfasc186 and Nfasc155 
are closely associated with the integrity of myelin and axons since they have 
important roles in the assembly of nodal and paranodal domains during myelination 
and node of Ranvier maintenance (Sherman et al., 2005, Zonta et al., 2008). 
However, little is known concerning how areas of inflammation, demyelination or 
remyelination in the multiple sclerosis brain could influence the composition and 
integrity of the nodal components. 
 
One of the studies has focused on the expression pattern of Nfasc155 and Nfasc186 
to determine the changes that occur at the node of Ranvier during the formation and 
repair of multiple sclerosis lesions (Howell et al., 2006). In that study it was shown 
that in sections of MS post-mortem brains, significant changes in Nfasc186 and 
Nfasc155 expression and localization were found in the demyelinated areas of 
lesions. The changes include highly elongated Nfasc186 staining and also elongated 




dephosphorylation associated with demyelination and this is known to be present to a 
large extent in active multiple sclerosis lesions (Trapp et al., 1998). Co-staining with 
anti-Nfasc155 showed that disruption of Nfasc155 expression is associated with 
early axonal pathology; also changes in Nfasc186 staining associated with axon 
pathology (Howell et al., 2006). Interestingly they found that Nfasc155 is disrupted 
in areas of inflammation around the lesions and Nfasc155 disruption precedes the 
changes at the node of Ranvier and Nfasc186 expression, which suggested Nfasc155 
changes start from the early phase of MS disease before demyelination and 
remyelination (Howell et al., 2006). Also they found that the disruption of Nfasc155 
in remyelination plaques is less extensive compared with the demyelinated lesions 
(Howell et al., 2006) indicating that Nfasc155 is involved in remyelination of the 
lesions in MS. 
 
Knowing that Nfasc155 is disrupted in areas of inflammation in MS, some studies 
have focused on the relationship between autoantibodies in MS patients and 
Neurofascins. Western blots using patient sera to probe Neurofascins in enriched 
brain lysates, it was reported that, out of 22 multiple sclerosis (MS) patients, ~20% 
percent of their sera had a prominent response to bands around 150-180 kD (band 
sizes varies between patients) (Fig. 6), which is approximate the size range of 
Nfasc186 and Nfasc155. Then by using two-dimensional gel electrophoresis and 
purified IgG from patients, they found Nfasc155 extracellular domains can be 
recognized by the autoantibodies from MS patients. They then showed those 
autoantibodies also recognize Nfasc186 (Mathey et al., 2007). By using an MS 
disease animal model, Mathey et al (2007) also explored the pathomechanisms 
related to Neurofascin autoantibodies. They found that transfer of Neurofascin 
antibodies exacerbated the clinical phenotype of Experimental Allergic 
Encephalomyelitis (EAE); also transfer of antibody only resulted in acute axonal 
damage in the absence of demyelination or increased inflammation in the CNS 
(Mathey et al., 2007). This suggested that the node of Ranvier is in a protected 
environment, the nodal protein components like Neurofascins do not encounter 
antibodies in normal situations. Furthermore, in vitro and vivo, Neurofascin 




were studied by Mathey et al, more patients are needed for a proper statistical study 
to understand whether autoantibodies of Neurofascin are pathogenetically significant. 
However, from animal models in their study, it suggested an initial breaking down of 
the myelin sheath is needed for the autoantibodies to cause damage. Hence, the 
effects of the autoantibodies of Neruofascin on human patients, if any, is likely to be 
caused by the demyelination in MS, instead of the trigger of MS. 
 
 
Figure 6. Antibodies to Neurofascins were identified in patients with MS 
(Mathey et al., 2007). 
Human myelin and the myelin glycoprotein (gp) fraction were separated by 
SDS-PAGE and blotted, and glycoproteins were detected using biotinylated 
lentil-lectin (left). Using this myelin glycoprotein fraction to screen patient sera 
identified antibody responses to a variety of components, including Nfasc155 
(right) (Mathey et al., 2007). 
 
However in human MS patients, axonal loss is responsible for the development of 
chronic neurological deficits (when Neurofascin antibodies are at the highest levels), 
but the pathomechanisms that initiate or exacerbate axonal injury in this 
inflammatory demyelinating disease remain obscure (Mathey et al., 2007). 
 
Neurofascin 155 low (Nfasc155-L) in MS 
In early studies (Schafer et al., 2004, Sherman et al., 2005), a single band 
representing Nfasc155 was revealed by western blot with standard electrophoretic 
separation of spinal cord homogenates from wild-type mice. However, two bands, 




extended electrophoresis of mice brain lysates (Pomicter et al., 2010). By using the 
brain lysate from a glial conditional Neurofascin knockout mouse CNP promoter-
regulated Cre expression (CNP-Cre/Nfasc
flox
) (Pillai et al., 2009), they found both 
Nfasc155-H and Nfasc155-L are expressed in glial cells. Interestingly, in two out of 
eight MS brain samples of donors, the expression level of Nfasc155-L was up 
regulated (Fig. 7) (Pomicter et al., 2010). It was suggested that Neurofascins are 
involved in some neuronal pathological changes, and also indicates new isoforms of 
Neurofascins also have possible active roles in neurological diseases. 
 
 
Figure 7. The pattern of Neurofascin 155H and Neurofascin 155L is altered in 
multiple sclerosis plaques (Picture from Pomicter et al., 2010) 
Normal-appearing white matter-multiple sclerosis (NM) and multiple sclerosis 
plaque (MS) samples from the same donors were run side by side on a Western 
blot. Results showing Neurofascin 155L is present only in the plaque samples 
(Pomicter et al., 2010). 
 
 
Neurofascin protein localization is altered in cerebral hypoperfusion.  
Cerebral hypoperfusion is suggested to contribute to the development of white matter 
changes in the aging brain (Fernando et al., 2006). A mouse model of chronic 
cerebral hypoperfusion, which mimics the modest, sustained reductions in blood 
flow of the aging brain, was used to analyze the integrity of Neurofascins and other 
key proteins at the paranodal and nodal regions in response to hypoperfusion. 
Immunolabeling showed that the number of Nfasc155 positive nodes is significantly 




3 days to 1 month after hypoperfusion, the loss of Nfasc155 became more 
pronounced (Reimer et al., 2011). In addition, EM images showed the number of 
septate-like junctions of paranodal loops in hypoperfused samples was highly 
reduced (Reimer et al., 2011). These authors also found in the corpus callosum and 
internal capsule the length of Nav channel staining at nodes was significantly 
increased after 3 days hypoperfusion. This seems likely to be the consequence of the 
loss of the diffusion barrier formed by Nfasc155-Caspr-Contactin complex. More 
interestingly, the observation of an intact length of Nfasc186 and AnkyrinG when the 
distribution of the Nav channels is extended was contrary to the view that Nfasc186 
might indirectly interact with Nav channels through AnkyrinG and ßIV spectrin. 
Further, it suggested that Nav channels can interact with other proteins rather than 
Nfasc186 and AnkyrinG. 
 
In all the above studies, it is still difficult to conclude that the Neurofascins have a 
key involvement in causing the major clinical phenotype of human disease; however, 
these studies do suggest that the Neurofascins and their autoantibodies may have 
roles in the pathological changes which happened during the process of disease. 
 
1.4.5 Neurofascin in kidney 
Neurofascins were thought to be only expressed in the nervous system, however, a 
recent study has shown that Neurofascins are expressed in kidneys and could have a 
role there (Sistani et al., 2013). By both RT-PCR and western blot, an isoform of 
Neurofascin was detected in the glomerular fraction of kidney, and based on its size 
on western blot it is Nfasc186. Immunofluorescence showed that the Neurofascin 
signal is very strong in the glomerulus, whereas no immunoreactivity was observed 
outside of glomeruli (Sistani et al., 2013). In the glomerulus, Nfasc186 was detected 
at the urinary side of nephrin staining and it seems to localize to the major processes 
marked with vimentin (Sistani et al., 2013). When different development stages of 
kidney were studied, Neurofascin was first observed at the capillary-stage 
glomerulus, where the staining colocalized with vimentin; then Neurofascin was 
detected both on the basal aspects and at the apical membrane of developing 




maturation Neurofascin is colocalized with the podocytes, which supports the idea 
that Nfasc186 associates with processes extended by podocytes (Sistani et al., 2013).  
 
1.5 Proteins that interact with Neurofascins  
1.5.1 Paranodal Nfasc155-Caspr-Contactin complex. 
Nfasc155 colocalized with Caspr and Contactin at the paranodal region and forms 
the Nfasc155-Caspr-Contactin complex and this complex forms the septate-like 
paranodal junctions that flank the node of Ranvier (Charles et al., 2002, Sherman et 
al., 2005). 
 
Nfasc155 is likely to have a pioneer role at the paranodes, because its targeting to the 
paranodes does not depend on the expression of Caspr and Contactin and it is 
required for the localization of the Caspr-Contactin complex (Charles et al., 2002). In 
conditional Nfasc155 knockout mice, like Contactin and Caspr knockouts, the 
organization of the paranodal loops was preserved; however, the characteristic 
transverse bands were absent. In addition, the spacing between the paranodal loops 
and the axolemma was often wider (Pillai et al., 2009). In summary, Nfasc155 
appears to initialize the assembly of the Nfasc155-Caspr-Contactin complex, but this 
complex needs all three proteins together to be functional and maintain the integrity 








Figure 8. Schematic representation of the molecular organization of the 
paranodal complex (Charles et al., 2002). 
The interaction of Nfasc155 (NF155 in picture) expressed in glial cells with 
Caspr and Contactin expressed in axons, forms the Nfasc155-Caspr-Contactin 
complex at the paranodes. 
 
Contactin 
Contactin is a neural glycosyl-phosphatidylinositol (GPI)-anchored IgSF cell 
adhesion molecule (Ranscht et al., 1998, Brümmendorf et al., 1989, Gennarini et al., 
1989, Berglund et al., 1994). Through cis and trans interactions Contactin interacts 
with multiple proteins, including Caspr and Nfasc155 (Peles et al., 1997, Volkmer et 
al., 1998). Contactin is expressed on axons and dendrites of diverse neuron 
populations. In vitro assays have revealed functions for Contactin in neurite 
extension Gennarini et al., 1991, Durbec et al., 1992, Peles et al.,1995), fasciculation 
(Chang et al., 1987, Rathjen et al., 1987), and repulsion (Pesheva et al., 1993). 
 
In Contactin knockout mice it was clearly shown that the paranodal junction is 
disrupted. The electron microscope (EM) images of the nodes of Ranvier in PNS 
showed the ultrastructure of paranodal junctions is abnormal (Boyle et al., 2001). 
The paranodal gap between the axolemma and the apposing myelin loops is 
significantly widened and also electron dense transverse bands that are thought to 
represent sites of direct adhesive contact between the terminal myelin loops and the 
axolemma are missing in Contactin knockout mice (Fig. 9). Moreover, 




mutants. Interestingly, Nfasc155 is still targeted to the paranodal region (Fig. 9) 
(Boyle et al., 2001).  
 
Figure 9. Immunofluorescence showing Nfasc155 is targeted to paranodes 
without Contactin and Caspr (Boyle et al., 2001). 
Immunolabeling showed that compared with controls (G,I,K) when Contactin is 
deleted (H) the Caspr is mislocalized (J), but Nfasc155 is still targeted to the 
paranodes (L). Scale bar, 5 µm. 
 
Caspr 
The adhesion molecule Caspr (Contactin associated protein, also named Paranodin) 
forms a complex with Contactin on axons that is concentrated at the paranodal 
junctions (Fig. 8) (Einheber et al., 1997, Menegoz et al., 1997, Peles et al., 1997, 
Rios et al., 2000). Caspr and Contactin are integral junctional components because 
mice deficient in these proteins exhibit severe disruptions of normal paranodal 
interactions (Bhat et al., 2001, Boyle et al., 2001, Rios et al., 2003). Similar to 
Contactin knockout mice, the Caspr mutant also has compact myelin sheaths in both 
CNS and PNS, whereas various abnormalities of the paranodal region were observed 
by EM on longitudinal sections. The abnormalities include the absence of the regular 
array of transverse bands between paranodal loops and the paranodal loops are 
severely disorganized in the paranodal region. Also immunolabeling shows the lack 
of Contactin but the presence of Nfasc155 at paranodes of Caspr in knockout mice 






1.5.2 Major nodal proteins 
Studies have identified many nodal proteins in both PNS and CNS; among them 
AnkyrinG, NrCAM Gliomedin and Brevican are shown/suggested to have direct 
interaction with Nfasc186 (Fig. 10). 
  
Figure 10. Schematic representation of the molecular organization of the 
nodal complex in both CNS and PNS (modified from Desmazieres et al., 2012). 
The major nodal proteins which have been identified at the nodes of Ranvier in 
both PNS and CNS. In the PNS, Gliomedin, NrCAM and AnkyrinG (AnkG) have 
been shown to directly interact with Nfasc186. Other proteins interact with 
Nfasc186 through AnkyrinG. In the CNS, Brevican is suggested to interact with 
Nfasc186 but this has not been confirmed yet. In the CNS, the other protein 
interactions are shown to be similar to PNS. 
 
AnkyrinG  
Ankyrins consist of three major domains: a membrane-binding domain with a 
common folding structure and 24 consecutive repeats (the MB domain), a spectrin-
binding domain (the S domain), and a death domain with the C-terminus (the DC 
domain) (Bennett et al., 2001). Biochemical studies suggest that ankyrins are 
multivalent molecules and can form lateral homophilic and heterophilic complexes 
between integral membrane proteins (Michaely et al., 1995). Of the three ankyrin 




myelinated axons and directly interacts with axonal Nav channels (Bennett et al., 
2001, Kordeli et al., 1995). In Neurofascin knockout mice, AnkyrinG fails to target 
to the nodes of Ranvier (Sherman et al., 2005), which supported the view that the 
intracellular domain of Neurofascin serves as part of the docking site for AnkyrinG 
(Davis et al., 1993). In conditional AnkyrinG knockout mice, Nav channels are 
absent from axon initial segments, and the neurons show severe deficits in action 
potential firing (Jenkins et al., 2001, Zhou et al., 1998). This indicates AnkyrinG has 
a very important role in clustering Nav channels to the AIS. However, the interaction 
between Neurofascin and AnkyrinG is not important for the formation of AIS (Zonta 
et al., 2011). Thus, the role of AnkyrinG in clustering of Nav channels to nodes of 
Ranvier remains unclear so far. 
NrCAM 
NrCAM is a neural cell adhesion molecule (CAM), like Nfasc186, that is enriched at 
PNS nodes (Davis et al., 1996, Lambert et al., 1997) and has been implicated in the 
assembly of nodes of Ranvier (Custer et al., 2003, Sherman et al., 2005 and Zonta 
et al., 2008). The observation that the binding of NrCAM-Fc fusion protein to 
Chinese Hamster Ovary (CHO) cells was dependent on Neurofascin expression 
(Lustig et al., 2001) and a study in the chick that NrCAM acted as a cell surface 
receptor for Neurofascin (Volkmer et al., 1996) both suggest there is a direct 
interaction between NrCAM and Nfasc186. The fact that expression of NrCAM-Fc 
protein inhibits AnkyrinG and Nav channel clustering in Schwann cell-neuron co-
cultures provided the first functional evidence for a role of CAMs in the development 
of the node of Ranvier (Lustig et al., 2001). Also Neurofascins and NrCAM can 
interact with AnkyrinG via their cytoplasmic domains (Bennett et al., 1999) and may 
thereby recruit Nav channels to the nodes through their interaction with AnkyrinG. 
NrCAM localization precedes Nav channel clustering at Schwann cell edges and also 
genetic deletion of NrCAM results in a delay in both Nav channel and AnkyrinG 
clustering but not in myelination. Nevertheless, nodes ultimately form properly in the 
absence of NrCAM. This suggests that NrCAM is involved in node development, but 






Gliomedin is an N-glycosylated trimeric molecule secreted by Schwann cells (SCs) 
and incorporated into the extracellular matrix (Eshed et al., 2005, Eshed et al., 2007, 
Maertens et al., 2007). Autoantibodies to Gliomedin as well as Neurofascins have 
been identified in experimental allergic neuritis, a model of Guillain-Barré syndrome 
(Lonigro et al., 2009). Soluble Neurofascins (Nfasc186 and Nfasc155) and NrCAM 
specifically bind to Gliomedin-expressing COS7 cells (Eshed et al., 2005). Also 
soluble Gliomedin can bind to Neurofascins and NrCAM expressing cells (Eshed et 
al., 2005). In another experiment, the FnIII domains of Nfasc186 were implicated in 
interaction with Gliomedin ( Labasque et al., 2011). All this suggested there are 
interactions between Gliomedin and Neurofascin. The exact function of Gliomedin is 
still unclear, but in the absence of Gliomedin Nav channels cannot target to the 
heminodes during myelination (Feinberg et al., 2011). Hence, it has been proposed 
that after glial NrCAM tethering Gliomedin to Schwann cell microvilli, the 
NrCAM/Gliomedin complex serves as a Schwann cell signal for Nav channel 
clustering at heminodes by binding to axonal Nfasc186 (Feinberg et al., 2011). 
 
Brevican 
Brevican is one of the most important neural proteoglycans in the mature brain. It 
constitutes a key component of perineuronal nets (PNN) and ECM, and the ECM is 
thought to be able to stabilize synapses in neural networks and inhibit neurite 
outgrowth (Yamaguch et al., 2000, Hockfield et al., 1990). When adding soluble 
GFP-Brevican, punctate GFP-Brevican binds to Nfasc186-transfected cells, but not 
to untransfected or NrCAM-transfected cells, which suggested that Brevican 
interacts with Nfasc186 (Hedstrom et al., 2007). In vivo investigation of Brevican 
shows that Brevican is not ubiquitously present at the nodes of all myelinated axons 
and is predominantly found at the nodes of large diameter axons in CNS (Bekku et 
al., 2009). Moreover, TN-R and phosphacan are only found at the nodes of Ranvier 
which express Brevican (Bekku et al., 2009). This suggests a crucial role of Brevican 
in creating a specialized matrix in such large diameter axonal nodes. Meanwhile, 




neurons during postnatal development, suggesting that they are structures integral to 
mature neurons. Brevican is also enriched at mature and developing nodes, 
suggesting that it may contribute to node formation and/or maintenance. However, 
the primary role of Brevican regarding to the nodes of Ranvier is still unclear. 
1.5.3 AIS proteins 
The molecular organization of the AIS has many features in common with nodes of 
Ranvier and juxataparanodes (Fig. 11). The AIS is comprised of ion channels 
(Nav1.x, KCNQ2–KCNQ3 and Kv1.x), cell adhesion molecules (NrCAM, Nfasc186 
a disintegrin and metalloproteinase domain-containing protein 22 (ADAM22), 
transient axonal glycoprotein 1 (TAG1, also known as contactin 2) and CASPR2), 
extracellular matrix molecules (brevican and versican), cytoskeletal scaffolds (AnkG, 
βIV spectrin and postsynaptic density protein 93 (PSD93)) and other signalling 
proteins(casein kinase II (CK2), phosphorylated nuclear factor-κB (pNFκB) and 
phosphorylated inhibitor of κBα (pIκBα)) (Rasband et al., 2010). Nfasc186 is 
dispensable for the assembly of AIS but in adult animals the Nfasc186 has a key role 






Figure 11. The protein composition of the AIS (Rasband et al., 2010). 
Diagram showing the major AIS proteins many of which have also been 
identified at the nodes of Ranvier in both PNS and CNS.  
 
Doublecortin  
When cultured hippocampal neurons are stained for Doublecortin (DCX) and 
Neurofascins, surface Neurofascins and DCX were not strikingly colocalized; 
however, there was a readily detectable intracellular pool of Neurofascins, which 
partially colocalized with DCX. This intracellular pool of Neurofascins was widely 
dispersed throughout the whole cell and did not cluster underneath the AIS (Yap et 
al., 2012). This suggested there is no direct interaction between Neurofascin and 
DCX. Interestingly, reducing DCX levels decreases the relative AIS enrichment of 
HA tagged Neurofascins; also endocytosis of HA tagged Neurofascin is stimulated 
when co-expressing DCX in PC12 cells. Endocytosis of endogenous Neurofascins is 
also diminished in neurons that do not express DCX (Yap et al., 2012). These 
observations indicate that though DCX and Neurofascins may not directly interact, 





1.6 Post translational modifications of Neurofascins. 
Besides differential splicing of the Neurofascin gene resulting in different isoforms 
of Neurofascins, Neurofascins can also undergo post translational modifications.  
 
1.6.1 Nfasc 155 is N-Glycosylated 
Glycosylation is a prime regulator of protein function such as protease activity (Steen 
et al., 2001), intracellular trafficking (Yan et al., 2008), protein binding (Milev et al., 
1995, Zhou et al., 2008) and stability (Buck et al., 2004, Gao et al., 2007, Li et al., 
2007). Peptide-N-Glycosidase F (PNGase F) is an amidase that cleaves complex 
oligosaccharides from N-linked glycoproteins. Electrophoresis of untreated and 
PNGase F treated Neurofascins side-by-side showed shifts on western blots induced 
by deglycosylation (Pomicter et al., 2010). In the same experiment they showed 
Nfasc155-H and Nfasc155-L both shifted but still retained 2 different sizes, which 
indicates that, although Neurofascins are glycosylated, the difference between 
Nfasc155-H and Nfasc155-L is not simply differential N-linked glycosylation 
(Pomicter et al., 2010). They also claimed that Nfasc155-H and Nfasc155-L may 
have distinct functions related to their different states of glycosylation (Pomicter et 
al., 2010). 
 
1.6.2 Neurofascin 186 is O-mannosylated  
Protein O-mannosylation is an important modification in mammals, and deficiencies 
of O-mannosylation have recently been associated with diseases like Walker–
Warburg syndrome and different forms of muscular dystrophies such as Muscle–
Eye–Brain disease and Fukuyama congenital muscular dystrophy (Kobayashi et al., 
1998, Bernabé et al., 2002, Shenoy et al., 2010). Although, it has already been shown 
that the amount of O-mannosyl glycans in brain is very high, only very few specific 
proteins have been identified as O-mannosylated (Pacharra et al., 2012). Electrospray 
ionization mass spectrometric analysis of peptides from endogenous Neurofascins 




Proxeon nano ESI-source and coupled to a Proxeon Easy nLC II system. Endogenous 
Nfasc186 from mouse brain was purified and analyzed. Several O-mannosylated 
peptides were identified, which are located all over the protein and not stringently 
within the Mucin domain as in α-dystroglycan, showing that O-mannosylation in 
mammals is independent of its Mucin domain (Pacharra et al., 2012). However, the 
possible function of O-mannosylation of Neurofascins is still not clear. 
 
1.6.3 Nfasc186 is phosphorylated 
Phosphorylation of proteins is an important regulatory mechanism, and many 
enzymes and receptors are activated or inhibited by phosphorylation and 
dephosphorylation. Reversible phosphorylation often results in a conformational 
change in the structure in many enzymes and receptors, causing them to become 
activated or deactivated. Neurofascins can be phosphorylated. Using an anti-
phosphotyrosine antibody, Neurofascins, especially Nfasc186, are tyrosine 
phosphorylated in vivo in a time-dependent fashion, with the maximal level of 
phosphotyrosine immunoreactivity present during the embryonic period (Garver et 
al., 1997). The same group also identified the highly conserved FIGQY tyrosine in 
the cytoplasmic domain as the principal site of phosphorylation (Garver et al., 1997). 
Meanwhile, by showing activation of tyrosine kinases or inactivation of tyrosine 
phosphatases completely eliminate the ability of Nfasc186 to coimmunoprecipitate 
ankyrins, they showed that phosphorylation of Neurofascins regulates the interaction 
between Nfasc186 and AnkryinG (Garver et al., 1997). 
 
N-Glycosylation, O-mannosylation and phosphorylation are the 3 identified post 
translational modifications of Neurofascins demonstrated in three different studies 
(Garver et al., 1997, Pomicter et al., 2010, Pacharra et al., 2012). However, the 
functions of those post translational modifications in vivo are still poorly understood. 
 
1.7 Domain functions of Neurofascins. 
The Neurofascin gene encodes six immunoglobulin domains, five fibronectin type III 




Those domains have different functions some of which have been revealed in recent 
studies. 
 
1.7.1 IgG domains 
A function of the IgG domains has been revealed by an in vivo study, in which 
Nfasc155 IgG5-6 domains were specifically deleted from glial cells in a transgenic 
mouse (Thaxton et al., 2010). In these mice after the deletion of IgG5-6, Nfasc155 
was still targeted to some of the paranodes. However, the Caspr fluorescence 
labelling showed a diffused and disrupted pattern; also, the Kv channels were 
redistributed into the paranodal space (Thaxton et al., 2010). Hence, the loss of 
Nfasc155 IgG5-6 alone in mice resembles the phenotypes of Nfasc155 conditional 
knockout mice, including paranodal disorganization and loss of paranodal septae 
junction (Pillai et al., 2009). This indicates that the IgG5-6 domains are important for 
the interaction between Nfasc155 and the Caspr-Contactin complex.  
 
Furthermore, in the same paper (Thaxton et al., 2010) the author used another animal 
model, in which the IgG5-6 of both Nfasc186 and Nfasc155 were deleted. But they 
found the nodal components were still targeted to the nodes normally, which 
included Nav channels and AnkyrinG. This suggested that the IgG5-6 domain is 
dispensible for the function of Nfasc186 at the formation and maintenance of the 
nodes of Ranvier. 
 
Nfasc186 lacking IgG5-6 and all FnIII domains was transfected into mouse 
neuroblastoma (N2a) cells, the NrCAM-Fc protein could still bind to the cells. 
However, after transfection with Nfasc186 lacking IgG1-6 domains, NrCAM-Fc 
failed to bind to the cells (Labasque et al., 2011). This suggests that there is a binding 
site at the IgG1-4 domains of Nfasc186 which interacts with NrCAM. It had been 
shown previously that the interaction between NrCAM and Neurofascin influences 
AnkyrinG and Nav clustering at the node of Ranvier (Lustig et al., 2001). Hence, 





1.7.2 FnIII Domains 
Pull-down assays have been performed by incubating extracts from HEK293 cells 
transfected with different truncated forms of Nfasc186 with Gliomedin-Fc covalently 
immobilized onto activated agarose beads. These showed that the deletion of either 
the IgG1-6 domains only or FnIIIA-D domainsonly of Nfasc186 did not affect 
interaction with Gliomedin. But the deletion of all these domains led to the abolition 
of interaction with Gliomedin (Labasque et al., 2011). Also, in the same paper 
(Labasque et al., 2011), the authors claimed that the Mucin domain is not implicated 
in Gliomedin binding based on previous observations (Koticha et al., 2006). Hence, 
it has been suggested that both IgG and FnIII domains have Gliomedin binding sites 
(Labasque et al., 2011). 
 
Without a Mucin domain Nfasc186 can bind with relatively high affinity to Schwann 
cells, which suggested that Nfasc186 without the Mucin domain can still bind to 
Gliomedin (Koticha et al., 2006). Furthermore, an Fc fusion protein containing only 
three FnIII domains of Nasc186 bound to Gliomedin expressing cells (Labasque et 
al., 2011). This supported the view of the importance of the FnIII domains of 
Nfasc186 in Gliomedin interaction.  
 
1.7.3 Mucin and FnIIIE domains of Nfasc186  
Mucin and FnIIIE domains are the domains specific to Nfasc186. It has been shown 
that the Mucin domain is O-mannosylated (Pacharra et al., 2012). No interaction 
between Mucin/FnIIIE domains and other nodal components at the nodes of Ranvier 
have been found thus far; but there is an indication that the Mucin and FnIIIE 
domains are involved in the regulation of cell adhesion and neurite out growth.  
 
An in vitro study using reaggregated cerebellar neurons has shown that when 
Nfasc186-Fc was expressed in L1-Fc expressing cells, cell adhesion was inhibited, 
although Nfasc155-Fc did not inhibit cell adhesion (Koticha et al., 2005). Subsequent 
domain analysis showed that the Mucin and FnIIIE domains together are sufficient to 




regulatory activity of Nfasc186-Fc on cell adhesion is associated with the Mucin and 
FnIIIE domains of Nfasc186. 
 
An in vivo study in chick compared the expression pattern of different isoforms of 
Neurofascins and their neurite outgrowth promoting activities (Pruss et al., 2009). 
The authors found the form of Neurofascin, Nfasc185 in chick, which is equivalent 
to Nfasc186 in mammals, inhibits neurite outgrowth in chick embryos. After 
showing Neurofascins and axonin-1 colocalized at E9, they found that the FnIIIE 
(fifth FnIII-like) domain is associated with a reduced binding capacity of 
Neurofascin to axonin-1. Because axonin-1 can strongly promote neurite outgrowth 
from chicken embryonic dorsal root ganglia neurons (Kuhn et al., 1991), the FnIIIE 
domain of Nfasc186 may also inhibit neurite outgrowth by reducing Nfasc186 
binding ability to axonin-1. 
1.7.4 Cytoplasmic domain 
FGFR1 (fibroblast growth factor receptor 1) belongs to the four known fibroblast 
growth factor receptors (FGFRs) families, which represent a highly diverse 
signalling system important for migration, proliferation, differentiation, and survival 
of many different cell types (Ornitz et al., 2001). Because endogenous Neurofascin 
co-precipitates with FGFR1, one study suggested Nfasc166 (an embryonic form of 
Neurofascin in chick) can promoter neurite outgrowth thorough FGFR1. However, 
only Nfasc166 but not Nfasc186 can co-precipitate with FGFR1. Interestingly, 
although both the Nfasc166 cytoplasmic/intracellular and extracellular domains 
could co-precipitate with FGFR1, only the intracellular domain of Neurofascins was 
both necessary and sufficient to promote neurite outgrowth (Kriebel et al., 2012). 
 
As mentioned earlier, the intracellular domain of Neurofascins may be modified by 
tyrosine phosphorylation at the FIGQY-motif (KDSLVDpYGEGGEGQFNEDG 
SFIGQpYTVRKD) (Kriebel et al., 2012). Interestingly, the phosphorylated FIGQY 
motif favours interaction with Doublecortin while it is accessible to AnkyrinG 
binding in the dephosphorylated state (Kriebel et al., 2012). Based on their tyrosine 
phosphorylation study, Garver suggested that the phosphorylation of FIGQY-motif 




during development (Garver et al., 1997, Kriebel et al., 2012). However, no evidence 
has been shown to support this idea.  
 
In summary, the IgG1-4 domains of Nfasc186 could be important for the formation 
of nodes of Ranvier through the interaction with NrCAM. The IgG5-6 domains of 
Nfasc155 are important for the interaction between Nfasc155 and the Caspr-
Contactin complex. IgG and FnIII domains have binding sites for Gliomedin. Mucin 
and FnIIIE domains of Nfasc186 can inhibit cell adhesion; and FnIIIE domain of 
Nfasc186 may also inhibit neurite outgrowth by reducing Nfasc186 binding ability to 
axonin-1. Cytoplasmic domain of Neurofascins was both necessary and sufficient to 
promote neurite outgrowth. And FIGQY-motif derived from the cytoplasmic domain 
of Neurofascin may regulate the localization of Neurofascins during development. 
1.8 Cerebellar developmental 
During embryogenesis, the developing cerebellum undergoes a series of sequential, 
morphological events such as neurogenesis, cell migration, axon pathfinding, 
dendritogenesis and synaptogenesis (Sotelo et al., 2004). During mid-gestation 
(E13.5) Purkinje cells (Fig. 12 orange) are produced in the cerebellar plate and move 
from the ventricular zone (VZ) of the cerebellar plate neuroepithelium (CPN) toward 
the rhombic lip migratory stream (RLS) and nuclear transitory zone (NTZ). At the 
same time, most or all Reelin-producing cells (Pax6 positive cells) (Fig. 12 green) 
are produced in the upper rhombic lip (URL) and migrate into the nuclear transitory 
zone (NTZ), which later on develops into deep cerebellar nuclei projection neurons 
and granule cells (Robert F. Hevner 2008, pp 141-158). In section 3.1.6 I asked if the 







Figure 12. Diagram explaining cellular migrations during cerebellar 
development (adapted from Robert F. Hevner 2008, pp 141-158).  
Within the developing cerebellum (E13.5) Purkinje cells (orange) migrate from 
the ventricular zone along radial glial cells (gray) through the intermediate zone 
(IZ) into RLS or NTZ. Reelin-producing cells (green) also migrate from the URL 





1.9 Purpose of this project 
This project comprised two parts, both related to the roles of the Neurofascins in the 
developing nervous system. The overarching hypothesis is that Neurofascins are 
important for the formation and maintenance of node of Ranvier, especially the 
clustering of Nav. 
1.9.1 Identify and characterize a third isoform of Neurofascin in mouse.  
A Western blot study showed three different isoforms of Neurofascins. However, 
only two major isoforms of Neurofascins have been well studied in mouse, Nfasc155 
and Nfasc186. These two isoforms have different domain compositions, they are 
expressed in different cells and have different functions in organizing nodes and 
paranodes during myelination. Knowing so much about the other two Neurofascins, 
questions about the third isoform, Nfasc140, start to emerge. This begs a number of 
questions: 
- What is the domain structure of Nfasc140?  
- When and where is Nfasc140 expressed?  
- Is Nfasc140 necessary and sufficient for formation of a functional node of 
Ranvier? 
In order to address these questions, this work aims to gain insight into Nfasc140 in 
the following ways: 
 Using western blot and RT-PCR analysis to establish the domain 
composition of Nfasc140. 
 Using western blot and immunofluorescence to study the expression of 
Nfasc140 in different animal tissues from different ages, and to establish 
where and when the protein is expressed 
 Using different transgenic animals to determine the cell type that 
expresses Nfasc140 
 Using transgenic approach to express Nfasc140 on a Neurofascin 
knockout background to study whether Nfasc140 can cluster Nav to the 





1.9.2 The relationship between intact paranodal axoglial junctions and Nav 
channels clustering. 
Different studies have shown conflicting observations and conclusions about whether 
paranodal axoglial junctions can promote the clustering of Nav channels at the nodes. 
Previous study in our lab has shown Nfasc155–Caspr–Contactin complex is 
sufficient to cluster Nav at the nodes using a transgenic animal line (Zonta et al., 
2008). But it has been suggested that our transgenic line may have epitopic 
expression of Nfasc155 in neurons (Thaxton et al, 2011). My question here is: 
 Can I find a different approach to exam the function of Nfasc155–Caspr–
Contactin complex in Nav clustering?  
 
In order to address the questions, this work aims to gain a better understanding of the 
role of paranodal axoglial junctions in clustering Nav channels in the following ways: 
 Generating a cre line in which cre is active in neurons only. 
 Using the cre line to delete all neuronal Neurofascins at early age but keep 
the glial Neurofascin expression under its endogeous promoter. 
 Studying the Nav clustering in this mouse line in which nodes are disrupted 
after the deletion of neuronal Neurofascins and Nfasc155–Caspr–Contactin 




2. Materials and Methods 
All mouse lines used in this work were of congenic C57Bl6 background. C57Bl6 
strain was chosen due to its robustness, easy breeding and availability of knowledge 
in its physiology and genetics. Most importantly, many neurobiological mutations 
have been generated and studied in this strain. 
 
All animal work conformed to UK legislation (Scientific Procedures) Act 1986 and 
the Edinburgh University Ethical Review policy.  
2.1 RT-PCR  
2.1.1 Full length Nfasc140 RT-PCR 
TRIzol® Reagent (Life Technologies) was used to extract mRNA from fresh tissues. 
After sacrificing animals, the whole brains or hindbrains from wild-type animals 
were taken immediately. Brain tissues were weighed and TRIzol® Reagent (1 mL 
TRIzol per 50–100 mg brain tissue) was added. After homogenization by hand in 
1.5ml tubes using plastic pestles RNA was purified according to the manufacturer’s 
instructions and the air dried RNA was dissolved in 30 µl water. 
 
To eliminate any DNA contamination, a DNase treatment was applied to the RNA 
solution. DNA-free™ Kit (Ambion) was used. Then a spectrophotometer 
(GeneQuant1300, GE healthcare) was used to measure the concentration of mRNA. 
An A260 reading of 1.0 is equivalent to ~40 µg/ml single-stranded RNA. The 
A260/A280 ratio is used to assess RNA purity. An A260/A280 ratio of 1.8 2.1 is 
indicative of highly purified RNA. 
 
Moloney Murine Leukemia Virus Reverse Transcriptase (M-MLV RT, Promega) 
was used to synthesize the first-strand of cDNA from mRNA. 2 µg of RNA was 
mixed with 0.5µg random primers in a total volume of 14 µl. This was heated to 
70°C for 5min and then cooled on ice immediately. The following were then added: 




water (25 µl in final volume). After mixing well the reactions were incubated for 60 
min at 37°C and 15 min at 42°C. The control group had water instead of M-MLV RT. 
 
After first-strand cDNA synthesis, cDNA was diluted 10 times and used as the 
template for the following full length Neurofascin PCR. 5 units of Phusion DNA 
polymerase (NEB) was used, the PCR primers were: M186EcoSalF1 (5'-
ATGGCCAGGCAGCAG GCGCCAC-3') M186 Not stop R1 (5'-
CCATCTATTCCCTTGCCTGA-3'). PCR program was : 1 cycle of 98 ° C 
denaturation for 5 min, 53.5°C annealing for 30 s, and 72°C extension for 130 s. 2 
cycle of 98°C denaturation for 1min, 53.5°C annealing for 30 s, and 72°C extension 
for 2min and 10 s. 37 cycle of 98°C denaturation for 30 s, 53.5°C annealing for 30 s, 
and 72°C extension for 130 s. The final extension was at 72°C extension for 5min. 
After running on a 1% agarose gel a single band was detected and sequencing 
showed it was the 140 kDa isoform of Neurofascin first described by the group of 
Vann Bennett in 1996. 
 
Primers used for sequencing the whole cDNA sequence were:  
T7    (5'-TAATACGACTCACTATAGGG-3') 
IG6R1  (5'-CCGAGGACCAGGTGGCCAAG -3') 
mFn3BR1 (5'-CGCCACTTGACAATGTAGCG -3') 
3DR1  (5'- AAGCGGTAACGCGACACTGG-3') 
Sp6   (5'-TATTTAGGTGACACTATAG -3') 
 
2.2 Construct preparation for transgenesis 
2.2.1 Thy-1-Nfasc140 (T140) strategy: 
To drive the expression of Nfasc140 with a Flag tag at its C-terminus under the 
control of the Thy-1 (thymus cell antigen 1) promoter, a vector with the full length 
Nfasc140 cDNA with a Flag tag sequence was generated. As the 5’-end (exon3-
exon19,sixIgG domains) of Nfasc186 and Nfasc140 are similar, hence, the 5’-end 




EcoRI and BamHI and ligated into the MP32 vector to introduce a SalI site at the 5’-
end of the sequence. 
 
mRNA was extract from P1 mouse brain and the first strand cDNA was synthesised 
using the same protocols above. Using Primers: Ig6186F1 (5'-GGCCACTC 
CAACTAACCGTTTG-3') and m186NotstopR1 (5'-
CCATCTATTCCCTTGCCTGA-3'), Nfasc140 3’-end segment (exon19 - exon33) 
was amplified from the first strand cDNA.  
 
A single step “patch” PCR (Squinto et al., 1990) using three oligonucleotide primers 
was used to add a Flag tag at the C-terminus of the Nfasc140 3’-end segment, 
upstream of the termination codon (TGA), as follow: the forward primer was 
Ig6186F1 (5'-GGCCACTCCAACTAACCGTTTG-3'). The first reverse primer 
(Flag1) added half the Flag sequence and it also included a Gly-Gly sequence to 
bridge the Nfasc140 and the Flag tag (5'-
TTGTCATCGTCATCCTTGTAGTCACCTCCGGCAAGGGAATAGA TGGCA-3'). 
The second reverse primer (Flag2) had the rest of the Flag tag, followed by a stop 
codon and a unique HindIII restriction site (5'-GGCCCAAGCTTTCACTT 
GTCATCGTCATCCTT-3').  
 
Optimized primer ratios were used. Approximately 20 ng of cDNA template were 
used in a total 50 µl PCR reaction containing Pfu polymerase buffer, 0.2 mM dNTPs, 
0.2 µM forward primer, 0.002 µM reverse primer FLAG1, 0.2 µM reverse primer 
FLAG2 and Pfu polymerase (1U, NEB). The PCR program is: 1 cycle of 98°C 
denaturation for 1 min, 5 cycles of 98°C denaturation for 30 s, 55°C annealing for 30 
s, and 72°C extension for 4 min. The first part of the PCR reaction favoured the 
amplification using the 5' and FLAG1 primers, after which conditions were modified 
to allow the 5' and FLAG2 primer pair to amplify the product generated from the 
first amplification. The second part of PCR included 25 cycles of 98°C denaturing 
for 30 s, 60°C annealing for 30 s and 72°C for 4 min. The last cycle was 72°C 





The PCR product was purified using the QIAquick PCR purification kit (QIAGEN). 
The PCR product of the Nfasc140 3’-end segment with Flag tag was digested by 
BamHI and HindIII and consequentially the 5’-end Nfasc140 segment with SalI site 
was released from the MP32 vector. Two segments were ligated at BamHI sites and 
the whole Nfasc140-Flag was then inserted into the NotI and HindIII sites of pSP72 
vector (Promega). The ligation was performed using 1 U of T4 DNA Ligase, Quick 
Ligase Buffer (New England BioLabs) at room temperature for 10 min. Competent 
XL1-blue cells were transformed (Sanbrook and Russell, 2001) and plated on Luria-
Bertani medium (LB) agar (Melford) containing 0.1 mg/ml Carbenicillin. 
 
In order to introduce another SalI site at the 3’-end, Nfasc140-Flag was cut with NotI 
and HindIII and inserted into vector pBlueScript SK. Then the Nfasc140-Flag was 
released from two SalI sites and dephosphorylated with alkaline phosphatase (NEB). 
pTSC21K vector (Lüthi et al., 1996) was digested with XhoI successively. 
Nfasc140-flag was then inserted into pTSC21K vector using the ligation method 
described above. Nfasc140-flag positive clones were grown overnight in 5 ml LB 
with 1mg/ml Carbenicillin and purified by SDS/alkaline lysis using a plasmid DNA 
purification kit (Nucleospin, Macherey-Nagel). Plasmids were then sent for 
sequencing to check for errors (DNA Sequencing Service, Dundee University). 
Sequencing primers:  
Fn3DF1 5’- CAGGCGGTTCAGAGTCCGAC - 3’  
ThyR2 5’ - GCTAGTGGTATGCATGGAGGGAG - 3’  
ThyF2 5’- GGCAAAGGACCTTAGGCAGTGT -3’  
 
The mouse Nfasc140-Flag was cloned into the XhoI site of the pTSC21k vector and 




       
Figure 13. Schematic representation of the Thy1-Nfasc140-flag vector. 
Red portion of the vector represents the Nfasc140-flag cDNA which was 
inserted into the XhoI site of the vector. The blue and segments show the 
backbone of the Blue Script and Thy-1 Expression cassette.  
 
2.2.2 Thy-1-Cre strategy: 
The pCreERT2 vector (Feil et al., 1997 and Imai et al., 2001) was used as the 
template to amplify the Cre sequence. A primer pair was designed to introduce 2 
XhoI sites on each side of the DNA and a Kozak sequence just before the Cre 
sequence. The forward primer is CRE FW: (5’-
GCGCTCGAGACCATGTCCAATTTACTGACC GTAC-3’); the reverse primer is 
Cre RV: (5’-CGCCTCGAGCTAATCGCCAT CTTCCAGCAG-3’).  
 
Approximately 20 ng of cDNA template were used in a total 50 µl PCR reaction 
containing Pfu polymerase buffer, 0.2 mM dNTPs, 0.2 µM forward primer, 0.002 
µM reverse primer FLAG1, 0.2 µM reverse primer FLAG2 and Pfu polymerase (1U, 
NEB) The PCR program is: 1 cycle of 98°C denaturation for 30 s, 55°C annealing 
for 30 s, and 72°C extension for 40 s. 10 cycle of 98°C denaturation for 10 s, 55°C 
annealing for 30 s, and 72°C extension for 40 s. 25 cycle of 98°C denaturation for 10 
s, 65°C annealing for 30 s, and 72°C extension for 40 s. 1 cycle of 98°C denaturation 





15 µl PCR product was digested with 20 units of XhoI in 37°C for 2 h, and then 
heated to 65°C for 15 s to inactivate XhoI. De-phosphorylation was performed on the 
PCR product. 4 µl buffer 10x, 1 µl alkaline phosphatase (NEB.) 5 µl H2O, 30 µl 
digested DNA were mixed and put into 50°C for a 30min reaction. 
 
Using the ligation method mentioned before, the Cre was cloned into the XhoI site of 
the pTSC21k vector (Lüthi et al., 1997) and was released using NotI (Fig. 14). 
      
Figure 14. Schematic representation of the Thy1-Cre vector. 
The yellow portion of the vector represents the Cre gene which was inserted 
into the XhoI site of the vector. The blue and green segments show the 
backbone of the Blue Script and Thy-1 Expression cassette.  
 
2.2.3 DNA purification for injection 
Dr Barbara Zonta purified the DNA for microinjection. Briefly, prokaryotic 
sequences were removed by NotI digestion of 50 µg of plasmid, followed by 
purification of the insert on 0.8% low melting point agarose gel electrophoresis. The 
transgene was excised and the agarose was digested with Gelase (Epicentre 
Biotechnologies) according to the manufacturer’s instructions. The DNA was then 
purified on an Elutip-D column (Whatman), followed by ethanol precipitation and 
resuspension in injection buffer (0.1 mM EDTA, pH 8.0, 10 mM Tris HCl, pH 7.5). 




Finally, the purified DNA was diluted with injection buffer to obtain a final 
concentration of 2.5 µg/ml. 
2.2.4 Pronuclear microinjections of DNA 
Pronuclear microinjections of the transgene and embryo transfers (Hogan et al., 1994) 
were performed by Heather Anderson. Briefly, fertilized oocytes were obtained from 
super ovulated C57BL6/CBA F1 hybrid female mice mated with F1 hybrid males. 
After injection, fertilized eggs at the one or two-cell division stage were transferred 
into pseudo-pregnant MF1 foster mothers. Genotyping using ear biopsies was done 
at approximately P21. 
 
2.3 Animals and genotype screening 
All animal procedures reported in this work were performed according to Home 
Office regulations, Animals (Scientific Procedures) Act 1986. 
2.3.1 Nfasc
-/-
 mice  
Nfasc
-/-
 mice were generated by homologous recombination in ES cells as previously 
described (Sherman et al., 2005). Briefly, the targeting construct was designed to 
generate S129 ES cells clones with a deletion of exon 5 (3 kb), which introduces a 
frame shift resulting in a stop codon in exon 6. One clone with the desired 
modification (2D7) was then injected into C57Bl/6-derived blastocysts, transferred 
into pseudo-pregnant mothers to generate chimeras. Nfasc
+/- 
mice were backcrossed 
to a C57BL/6 background for at least six generations before experimental analysis. 
Since Nfasc
-/-
 mice die by postnatal day (P) 7, litters were harvested at P6 and 
identified by genotyping using biopsy. 
2.3.2 Nfascflox mice 
Nfasc
flox
 mice were generated in our lab as previously described (Zonta et al., 2011). 
Using the same strategy as the one used for Nfasc
+/- 
mice, but with an alternative 
excision where only the PGKneo-HSVtk cassette was removed and where the 




2.3.3 Transgenic mice T140  
The vector with Flag tagged Nfasc140 driven by the Thy-1 promoter was digested 
with Not I to release the transgene. The DNA purification and injection was 
conducted as described before (2.2.3 DNA purification for injection and 2.24 
Pronuclear microinjections of DNA). Transgenic founders were identified by PCR 






2.3.4 Transgenic mice T186 
The T186 transgenic mouse line was generated by Dr Barbara Zonta and Dr Anne 
Desmazieres (Zonta et al., 2011). The full length Nfasc186 cDNA with a flag tag was 
inserted in to the pTSC21k vector (Lüthi et al., 1997) and was released using NotI. 
And the transgenic mice were generated as for T140 mice.  
 
2.3.5 Generating Nfasc-/-/T140 and Nfasc-/-/T186 mice 
Since Nfasc
-/- 
die at p7, Nfasc
+/-





/T140 was interbred with Nfasc
+/-





/T186 was generated using the same breeding strategy. The genotyping PCR 
procedures for all those animals will be described later.  
 
2.3.6 Ear and tail biopsies 
Ear biopsies were digested overnight at 55ºC in 50 µl lysis buffer (150 µl for 5 mm 
tail clips). 50 µl lysis buffer contained 50 mM TRIS, 50 mM pH 8.0 EDTA, 0.25% 
SDS and 1.3 µl Proteinase K (1mg/ml, Roche). After digestion, unpurified lysate was 
vortexed, spun briefly and the supernatant was diluted 1:10 in double distilled 
(MilliQ) water. For PCRs, 2 µl of the ear or tail diluted digests were added to the 





2.3.7 PCR for colony and animal biopsies  
For animal tissues, the PCR reactions were performed in a total 25 µl consisting of 1 
X Go Taq Buffer, 1.5 mM MgCl2, 0.2 mM dNTPs, 0.5 µM of primers and 1 U of Go 
Taq polymerase (Promega) in MilliQ water. Positive and negative controls were 
always included alongside the test samples. 
 
For colony PCR, colonies which were grown on agar plates and single colonies were 
randomly picked and resuspended in 5 µl LB. And 2 µl of them were added to the 
PCR reaction as DNA templates. 
 
The PCR conditions for Go Taq polymerase (Promega) were: 1 cycle 94°C 
denaturing for 2 min, 57°C annealing for 30 s and 72°C extension for either 1 min or 
30 s according to the size of the product. This was followed by 30 cycles of 94°C for 
40 s, 57°C for 30 s and 72°C for either 1 min or 30 s. The final step consisted of 
94°C for 40 s, 57°C for 30 s and 72°C for 2 min. (according to different PCR 
program the annealing temperature and extension time vary.) 
 
According to the size of the PCR products, they were resolved on 0.8-2% agarose gel 
in TAE buffer containing 0.5 µg/ml ethidium bromide and visualised by UV 
transillumination (Uvitec, Cambridge). 
 






To identify the Neurofascin heterozygous (Nfasc
-/+
) or Neurofascin knock out 
(Nfasc
-/-
) mice, the primers were designed to flank exon 4. The forward primer 
NFFW1 (5'-GTGCTGATCCAGCCTAAAGC-3') and the reverse primer NFRV1 (5'-
TCAGCTGTTTTGAGCCACAC-3') generated approximately a 1.1 kb and a 700 bp 
products in wild type and null mice respectively (Fig. 15). The PCR conditions were: 
1 cycle of 94ºC denaturation for 1.5 min, 55ºC annealing for 30 s, and 72°C 




and 72ºC extension for 1 min 10 s. Finally, the last cycle consisted of 94ºC for 40 s, 






Figure 15. PCR diagram showing the genotyping result of Wild-type, 
Neuorfascin knock-out and heterozygous mice. 
PCR of DNA from a WT mouse generated a product with the size of around 
1.1kb. The Nfasc-/- generated a band at around 700bp. And PCR of the Nfasc+/- 
generated two bands at both 1.1kb and 700bp. 
 
T140 PCR 
To identify the flag tagged full length Nfasc140 PCR was performed by using a 
forward primer En3DF1: (5'-CAGGCGGTTCAGATCCGAC-3') located at the 
Fibronectin IIID domain and a reverse primer 186flag2: (5'-
GGCCCAAGCTTTCACTTGTCAT CGTCATCCTT-3') located at the FLAG tag 
sequence. The transgene generated a PCR product of approximately 500 bp (Fig. 16). 
The PCR conditions consisted of 1 cycle of 94°C denaturation for 2 min, 58°C 
annealing for 30 s, 72°C extension for 40 s, followed by 33 cycles of 94°C for 40 s, 
58°C for 30 s, and 72°C for 40 s. The final cycle consisted of 94°C for 40 sec, 58°C 





Figure 16. PCR diagram showing the genotyping result of T140 transgenic 
mice. 




To identify the flag tagged full length Nfasc186, a PCR was performed by using a 














Fibronectin IIIE domain specific for Nfasc186 and a reverse primer 186flag2: (5'-
GGCCCAAGCTTTCACTTGTCATCGTCATCCTT-3') located at the FLAG tag 
sequence. The transgene generated a PCR product of approximately 600 bp (Fig. 17). 
The PCR conditions consisted of 1 cycle of 94°C denaturation for 2 min, 56°C 
annealing for 30 s, 72°C extension for 40 s, followed by 33 cycles of 94°C for 40 s, 
56°C for 30 s, and 72°C for 40 s. The final cycle consisted of 94°C for 40 sec, 56°C 





Figure 17. PCR diagram showing the genotyping result of T186 transgenic 
mice. 
Genomic DNA from Thy1-Nfasc186Flag transgenic mice generated a PCR 
product of 600 bp. 
 
Thy-1-Cre PCR 
To identify the mouse carry Thy-1-Cre, PCR was performed by using a forward 
primer F6: (5'-CCAATTTACTGACCGTACACC-3') and a reverse primer R4: (5'-
AGCGTTTTCGTTCTGCCAAT-3') both of them located at the Cre sequence. The 
transgene generated a PCR product of approximately 600 bp (Fig. 18). The PCR 
conditions consisted of 1 cycle of 94°C denaturation for 2 min, 56°C annealing for 
30 s, 72°C extension for 40 s, followed by 33 cycles of 94°C for 40 s, 56°C for 30 s, 
and 72°C for 40 s. The final cycle consisted of 94°C for 40 sec, 56°C for 30 sec, and 





Figure 18. PCR diagram showing the genotyping result of Thy-1-Cre transgenic 
mice. 
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To identify the mouse carry loxP flanked Neurofascin allele/alleles, PCR was 
performed by use of a forward primer NFFW1: (5'-
GTGCTGATCCAGCCTAAAGC-3') and 2 reverse primers NFLS1R: (5'-
TGCGAAGTTATGGGCCCCAG-3') and NFLS2R: (5'-
CCTCTCCAAGCAGAGTACTC-3'), they located at the both sides of the exon4 of 
Neurofascin sequence. The WT generated a PCR product of 917 bp and the 
transgene generated a PCR product of 414 bp (Fig. 19). The PCR conditions 
consisted of 1 cycle of 94°C denaturation for 2 min, 60°C annealing for 30 s, 72°C 
extension for 1 min 10 s, followed by 36 cycles of 94°C for 40 s, 60°C for 30 s, and 
72°C for 1 min 10 s. The final cycle consisted of 94°C for 40 sec, 60°C for 1min, and 






Figure 19. PCR diagram showing the genotyping result of LoxP flanked 
Neuorfascin mice. 
PCR of WT mouse generated a product of around 1kb. The Nfascfl/fl had a band 
at around 400bp. And PCR of the Nfascfl/+ generated bands at both 1kb and 
400bp. 
 
2.4 Indirect Immunofluorescence 
2.4.1 Tissue fixation and preparation for immunostaining 
Mice at different ages, from adult to P6, were anesthetised with an intraperitoneal 
injection of euthatal (50-60 µl per adult and p6 animal). To perfuse the animal, 4% 
paraformaldehyde in 0.1 M phosphate buffer (PB) was injected through the left 
ventricle, pH 7.4. 20 ml paraformaldehyde PB solution was used per adult mouse and 
10 ml paraformaldehyde PB solution was used per P6 mouse during perfusion. After 
perfusion, whole brains and cervical spinal cords (C2-C7) were dissected out and 











harvested and post-fixed for 15 min at room temperature; brains from young and 
adult mice were post-fixed for 3 h.  
2.4.2 Frozen-sections 
The preparation for immunostaining: specimens were washed 3 X 10 min in 0.1 M 
PB and cryoprotected in 5% sucrose in PB for 2 h, 15% sucrose in PB for 2 h and 
then in 25% sucrose in PB at 4°C overnight. Tissue samples were oriented 
appropriately in O.C.T. embedding matrix compound (CellPath Ltd) and frozen with 
dry ice cooled isopentane. The blocks were then stored at -80°C until use. 
Consecutive 10-14 µm parasaggital brain sections and transverse sections of cervical 
spinal cords were cut using a Leica CM 3050 S cryostat and collected on 3-
aminopropyltriethoxysilane (TESPA)-coated glass slides. Sections were dried and 
stored at -20ºC until use. 
2.4.3 Teased fibre preparation  
After fixation, quadriceps and sciatic nerves and cervical spinal cords were washed 
in PBS 3 X 10 min each and placed in a 35 mm Petri dish. The perineurium of 
quadriceps and sciatic nerves was removed and fibre bundles were separated using a 
pair of acupuncture needles, in PBS on TESPA-coated slides.  
 
Cervical spinal cords were placed in the Petri dish with the ventral side facing up and 
the ventral funiculus or columns were carefully peeled from either side, very close to 
the central gulf (the median fissure), with fine forceps. Small fragments of tissue 
were then placed in a drop of PBS on TESPA-coated slides. Using acupuncture 
needles, by gently pushing or dragging the small tissue on slides the single fibres 
were separated from the bulk of the tissue. Teased fibres slides were air dried for 
immunohistochemistry or stored at -20°C for future use.  
 
2.4.4 Immunostaining and photo acquisition 
Teased fibres and fixed tissue sections on glass slices were first treated with blocking 
buffer (5% fish gelatin, 0.1% TritonX100 for teased fibres or 0.15% TritonX100 for 




antibodies were diluted accordingly in the same blocking buffer and applied on slices 
overnight at room temperature. The slices were washed with PBS for 5 times, each 
time for 5 min and fluorescent-conjugated secondary antibodies were applied in 
blocking buffer for 1 h and 15 min at room temperature. After blocking, the slices 
were washed with 0.1% Tween20 in PBS 5 times, 5 min for each wash. The slices 
were then mounted with Vectashield (Vector Laboratories.) 
 
The primary and secondary antibody dilutions are included in the section 2.8 
Antibodies used for immunolabelling.  
 
To acquire images for morphological analysis, an Olympus BX60 microscope 
equipped with a Hamatsu ORCA-ER digital camera and OpenLab software (version 
5.0) was used. All high magnification immunofluorescent photos were acquired 
using a Leica TCL-SL confocal microscope and proprietary software (Leica confocal 
softer ware version 2.6.1). FITC, TRITC and Alexa Fluor-647 fluorophores were 
excited with an Argon (488 nm) and HeNe (543 nm) laser respectively. For each 
photo, 4 (6 for AIS pictures) images at different points along the Z-axis were scanned 
and the maximum projection of the Z series were used. Photos were rendered using 
Photoshop CS6 (Adobe). 
 
2.5 Western Blot 
2.5.1 Protein extraction 
Animals were sacrificed by treatment with CO2 or by cervical spinal cord dislocation. 
Animal tissues such as brain, spinal cord and peripheral nerves were frozen in dry ice 
or liquid nitrogen immediately. Frozen tissues were store in -80°C. Phosphate buffer 
saline (PBS) with 1x Complete protease inhibitor cocktail (Roche) and 1 mM PMSF 
was cooled on ice to be used as the homogenization buffer. 
 
For CNS tissues, brain and spinal cord, 200 µl of homogenization buffer with 1% 
sodium dodecyl sulfate (SDS) were added to 0.04 g tissue (for P30 and older animals, 




and a plastic pestle was attached to a drill (Black&Deker, 450W) to homogenise the 
tissues. The lowest drill spin speed was used to homogenise tissue for 30-60 s, and 
the tissue lysates were on ice and cool all the time. After homogenization, a 13,000 
rpm centrifugation was applied to the lysate for 1 min and the supernatant was 
carefully moved to another tube. Protein concentration was estimated using the BCA 
(Bicinchoninic acid) assay (Pierce). And an appropriate amount of sodium dodecyl 
sulfate (SDS), dithiothreitol (DTT) and 4X sample buffer (20% glycerol, 130 mM 
Tris pH 6.8, bromophenol blue) were added into the lysate so that the lysate should 
have a final concentration of 4% SDS, 100 mM DTT and 1X sample buffer. The 
lysate was then mixed quickly and boiled for 10min. 
 
For PNS tissues, nerves nerves were homogenized in 50 µl of RIPA buffer (50 mM 
Tris pH 7.5, 150 mM NaCl, 1% NP-40, 0.1% SDS, 0.5% sodium deoxycholate, 1 
mM EDTA) containing phosphatase and proteinase inhibitors on ice for 25 min. 
After centrifugation at 13000 rpm at 4
o
C for 20 min, the supernatant was recovered. 
Protein concentration was determined and proteins were prepared as described above.  
 
2.5.2 Immunoblotting 
SDS-Page gels were poured in a casting frame (Bio Rad). Each running gel 
contained 5-15% acrylamide, 0.375 M pH8.8 Tris, 0.1%SDS, 0.1%APS, 0.1-0.05% 
TEMED. The stacking gel was 5% acrylamide, 0.12 M pH 6.8 Tris, 0.1%SDS, 
0.1%APS, 0.1-% TEMED. After loading samples into the wells, the gel was run with 
running buffer (25 mM Tris, 192 mM glycine, 0.1% SDS, pH8.3) at 180V, until the 
blue dye reached the bottom of the gel. 
 
The gel was transferred to nitrocellulose membrane (Whatman, Protran) in buffer 
containing 25 mM Tris HCl pH 8.3, 250 mM glycine and 20% methanol for 2 h at 
400 mA inside a transfer tank (Hoefer). The membrane was blocked overnight at 4ºC 
in 5% skimmed milk, 0.1% Tween 20 in PBS.  
 
To detect specific proteins, the membrane was incubated with primary antibodies, 




immunolabelling) with blocking buffer containing 0.2% gelatine, 0.1% Tween20 in 
PBS for 1 h at room temperature. After 6 times 5 min washes in blocking buffer, the 
membrane was incubated with species-specific HRP-labelled secondary antibodies 
for 45 min at room temperature. The excess of secondary antibody was removed by 6 
times 5 min washes in PBS and detected using the enhanced chemiluminescence 
(ECL) method (Santa Cruz Biotechnology). 
2.6 Quantitative analysis 
2.6.1 Quantification of nodes with Nfasc186 and Nav channel immunoreactivity 





(3 animals each), teased fibres from both CNS 
(ventral columns of cervical spinal) and PNS (quadriceps nerves) were labelled with 
various antibodies. Teased fibres were triple-labelled with NFC-2, MNF-2 and Nav 
channel. NFC-2 was used as a marker of both nodal protein Nfasc186 and paranodal 
protein Nfasc155. MNF-2 was used to detect Nfasc186 only at the nodes. 
 
Confocal images of 40 nodes per animal under the same condition were randomly 
chosen from different axons and captured. Two animals were used in each condition. 
Only the nodes which had been flanked by two paranodes were chosen and used for 
statistical analysis. Means of percentage of Nfasc186 and/or Nav channel positive 
nodes and were calculated using Excel.  
 
2.6.2 Protein level measurement on western blots. 
Western blot was scanned with Epson scanner (3200). The relative density for 
proteins samples were measured using softer ware ImageJ 1.47t (National Institutes 
of Health) according to the method from http://lukemiller.org. Basically, it measures 
the size and intensity of the protein band on western blot and comparing two bands it 
gives the relative density between 2 bands. And also by comparing the loading 





2.7 Physiology and behaviour analysis 
2.7.1 Nerve Conduction Velocity 
Femoral nerves and their quadriceps branch were carefully dissected from WT, T140 
and T186 mice at the age of 2 months (n=6), and maintained in oxygenated 
mammalian HEPES physiological solution which contains 137 mM NaCl, 5 mM 
KCl, 2 mM CaCl2¬, 1 mM MgCl2¬, 5.5 mM D-glucose and 5 mM HEPES, pH 7.2-
7.4. For periods of no longer than 15 min, nerves were transferred and placed on an 
array of silver electrodes (Fig. 21 A) with 1 mm intervals in a chamber and 
surrounded by 37oC liquid paraffin to isolate nerves from other electrical 
interference. Compound action potentials (CAP) were recorded from the distal end of 
the quadriceps branch by stimulating the proximal end of the femoral or quadriceps 
nerve with a square wave (0.15 ms, 0.8-2.5 V, mostly around 1 V). Depending on the 
length of the nerves, a few recordings were required at different conduction distances. 
The conduction distance was altered from 5 mm to max. 11 mm by connecting the 
stimulating electrode to different silver electrodes array successively at a decreasing 
distance from the recording electrodes. According to the wave shapes of CAP signals, 
the voltage of stimulus was adjusted to make the wave shapes and wave amplitude 
between nerves are similar in order to ensure the stimulation of a similar sub-group 
of nerve fibres (Fig. 20B). Signals of CAP were converted to digitized signals using 
Scope software (PowerLab/Scope data acquisition system from AD instrument and a 
Mac computer). Latencies of the onset of CAP were measured, which is the time gap 
between the starting of stimulation and the appearance of the peak of the CAP for all 
conduction distances(Fig. 20B). The conduction velocity was calculated from the 
slope of the regression line by plotting conduction distances against the 
corresponding latencies. Recordings were repeated 2-3 times for each nerve. The 
conduction velocity per animal was determined by averaging the mean conduction 










Figure. 20 Diagram of recoding a compound action. 
A. The schematic picture showing a never on an array of electrodes. And 
the electrode was connect to the stimulate from silver electrodes no.15 
towards no.1 when stimulating the nerves.  
B. The wave shape of a CAP signal was demonstrated there. The latency of 







 mice (4 per group) were trained on 
a 5-lane mouse RotaRod (Ugo Basile) for two consecutive days before the test on 
day 3. Animals were placed on a rotating RotaRod (3-cm diameter) sequentially at 
24 rpm and 32 rpm for a maximum of 60 s, four times at each speed. Each trial run 
was separated by a 10 min rest period. During the 60 s, mice were removed from the 
RotaRod either when they fell off the rod or they hold the rod rotating with rod for 2 
cycles. The mean latency of each mouse to fall or rotate with rod, which measures 
the length of time each animal was able to stay on the rod, was determined by the 
mean latency from the four trials for each rotating speed obtained on day 3. 
 
2.8 Statistics 
All statistical analysis was performed and graphs were produced using GraphPad 
Prism (version 5.0c). All values are expressed as mean  SEM. Unpaired, two-tailed 
Student’s t- test was used to determine statistical significance between 2 groups of 





comparison post-test was used to assess p values between multiple samples (3 or 
more unpaired groups). 
 
2.9 Antibodies used for immunolabelling 
The following tables show the antibodies used for indirect immunofluorescence (IF) 
and Western blotting (WB), also their working dilutions is shown here.  
 
Table 1. Primary antibodies 
Antibody name Species Source Dilution  
Anti  Actin (2-15) Rabbit P.J. Brophy 1:10000 (WB) 
Anti III Tubulin  Mouse, monoclonal IgG2b Sigma 1:500 (WB) 
Anti IV Spectrin Rabbit P.J. Brophy 1:200 (IF) 
Anti Ankyrin G Mouse, monoclonal IgG1  Calbiochem 1:50 (IF) 
Anti Ankyrin G rabbit V. Bennett 1:1000 (IF) 
Anti Calbindin D-28K Mouse, monoclonal IgG1 Sigma 1:1000 (IF) 
Anti Calbindin D-28K Rabbit Swant 1:5000 (IF) 
Anti CASPR Mouse, monoclonal IgM M. Rasband 1:50 (IF-WB) 
Anti CASPR Rabbit D.Colman 1:5000 (IF) 
Anti FLAG M2 Mouse, monoclonal IgG1 Sigma 1:400 (IF) 
Anti GFAP (GA5) Mouse, monoclonal IgG1  Boehringer 1:100 (IF) 
Anti L-MAG Rabbit P.J. Brophy 1:2000 (IF) 
1:4000 (WB) 
Anti-MBP Chicken, IgY Chemicon 1:25 (IF) 
Anti MBP (peptide 7) Rabbit P.J. Brophy 1:2000 (IF) 
1:5000 (WB) 
Anti MNF-2(Nfasc186) Rabbit P.J. Brophy 1:400 (IF) 
1:2000 (WB) 
Anti NFC1 (Pan Neurofascin) Rabbit P.J. Brophy 1:1000 (IF) 
1:2000 (WB) 





Anti NFF3 (Nfasc155) Rabbit P.J. Brophy 1:1000 (IF) 
1:2000 (WB) 
Anti NF-H 200kD Mouse, monoclonal IgG1  Sigma 1:200 (IF) 
Anti NrCAM (1) Rabbit P.J. Brophy 1:200 (IF) 
Anti OSP/Claudin 11 Mouse, monoclonal IgG2a A. Gow 1:100 
Anti OSP/Claudin 11 Rabbit Zymed  1:50(IF)  
1:500 (WB) 
Anti Pan Nav channels Mouse, monoclonal IgG1 Sigma 1:100 
 
 
Table 2. Secondary antibodies 
Antibody name Species Source Dilution 
Alexa Fluor-568-conjugated anti mouse IgG2b Goat  Molecular Probes 1: 1000 
Alexa Fluor-647-conjugated anti mouse IgG1 Goat Molecular Probes 1:200 
Alexa Fluor-647-conjugated anti rabbit IgG Donkey Molecular Probes 1:300 
FITC-conjugated anti chicken IgY Donkey Jakson 1:50 
FITC-conjugated anti mouse IgM Goat Southern Biotec 1;100 
FITC-conjugated anti rabbit IgG Goat Cappel  1:200 
FITC-conjugated anti-goat IgG Donkey Jackson 1:100 
FITC-conjugated anti rabbit IgG Donkey Jackson 1:100 
HRP-conjugated anti mouse IgG Goat Jackson 1:2000 
HRP-conjugated anti rabbit IgG Goat Jackson 1:50,000 
HRP-conjugated anti sheep IgG Donkey SAPU 1:2,500 
TRITC-conjugated anti mouse IgG1 Goat  Jackson 1:50,000 
TRITC-conjugated anti mouse IgG2a Goat Jackson 1:100 
TRITC-conjugated anti guinea pig IgG Donkey Jackson 1:150 






3. Results  
3.1 The study of Nfasc140  
3.1.1 Identifying the transcript of the third isoform of Neurofascin 
The Neurofascin (Nfasc) gene comprises 34 exons, with the ATG start site residing 
within exon 3. Previous studies have shown that Nfasc is transcribed to produce 
several isoforms generated by alternative pre-mRNA splicing (Volkmer et al., 1992, 
Volkmer et al., 1996, Hassel et al., 1997). 3 different isoforms of Neurofascin 
proteins were identified by western blot (David et al., 1996). However little is known 
about the third isoform of Neurofascin, named Nfasc140 based on its mobility on a 
SDS-gel (Davis et al., 1996). To determine the domains composition of Nfasc140, 
RT-PCR was conducted using mRNA extracted from WT (wild type) animals at 
different ages in order to first isolate the Nfasc140 cDNA. In previous studies 
Neurofascin transcripts were amplified in small segments, a strategy which has the 
potential to generate as yet unidentified potential Neurofascin isoforms consisting of 
different combinations of exons (Volkmer et al., 1996; Hassel et al., 1997). In order 
to reveal the sequence of Nfasc140 directly, I chose to clone all the possible 
Neurofascins transcripts from the known first coding exon to the last one by PCR. 
 
Two primers were used to clone the entire coding region of the Neurofascins 
(described in Materials and methods 2.1.1). Since the primer pair selected was not 
specific for a particular isoform of Neurofascin, multiple bands were anticipated. 
Interestingly, only single bands were generated from the RT-PCR reaction of WT 
mouse cDNA at E15.5, P17 and P30 (Fig. 21A). The reason that only a single band, 
instead of multiple bands, was observed in each RT-PCR could be that the 
concentration of mRNA of Neurofascins at different ages varies. Therefore only the 
predominate isoform of Neurofascins would be amplified by the RT-PCR reaction. 
Isolation of the resulting bands from the agarose gel and subsequent sequencing 




Nfasc186 or Nfasc155. Furthermore, the only Neurofascin transcript present in both 
P17 and P30 cDNA encoded Nfasc155. Sequence analysis and comparison by 
MacVector of the two major isoforms of Neurofascins (Nfasc186 and Nfasc155) 
with the newly identified transcript revealed that it lacked exons 5, 10, 24, 25 and 29-
31(Fig. 21B). Since this new transcript is smaller in size than the other two major 





Figure 21. Nfasc140 cDNA isolated by full length RT-PCR  
A. Full length RT-PCRs were performed on cDNA from E15.5, P17 and P30 
hindbrain tissues from WT mice. At E15.5, a new Neurofascin isoform was 
detected which was smaller in size compared to RT-PCR bands from Nfasc155 
in lane P17 and P30.  
B. Schematic representation of the Nfasc gene which contains 34 exons. Exon 3 
to exon 34 are the coding exons. The Nfasc140 sequencing result showed that 
it lacks the 5, 10, 24, 25 and 29-31 exons. 
 
3.1.2 Domain structure of Nfasc140 
After establishing the sequence of the Nfasc140 transcript, the domain structure of 
Nfasc140 was predicted based on the sequence and domain structures of Nfasc186 
and Nfasc155 (Fig. 22). Nfasc140 is predicted to have six IgG domains, the 






cytoplasmic domain. Nfasc140 lacks the FnIIIC and Mucin domains, specific for 
Nfasc155 and Nfasc186 respectively. 
 
Figure 22. The domain structure of Nfasc140, Nfasc186 and Nfasc155 
The domain structure of Nfasc140 was predicted based on the transcript 
sequence. Note that it does not have any unique domains when compared with 
Nfasc155 and Nfasc186 structure.  
 
To further confirm the domain structure of Nfasc140, three different Neurofascin 
peptide-specific antibodies were used to probe WT mouse brain lysates by Western 
blot. Since Nfasc140 has a high expression level at E15.5 (Fig. 24), comparison of 
WT brain homogenates at E15.5 and P60 would show whether Nfasc140 was also 
present in adult animals. Using an antibody raised to the cytoplasmic domain of all 
known Neurofascins, NFC1, specific bands corresponding to Nfasc186, Nfasc155 
and Nfasc140 were present (Fig. 23A). In contrast, the MNF2 antibody which is 
specific for the Mucin-like domain detected Nfasc186 at both E15.5 and P60 but did 
not detect Nfasc140 (Fig. 23B). Another antibody, NFF3, which recognizes the 
Nfasc155-specific FnIIIC domain, only detected Nfasc155 in WT brain homogenates 
at P60 and could not detect Nfasc140 (Fig. 23B). These data are consistent with the 
sequence data suggesting that Nfasc140 lacks the FnIIIC domain of Nfasc155 and 








Figure 23. Domain composition of Nfasc140 is confirmed by Western blot. 
A. Schematic picture showing regions of antibody specificity. MNF2 antibody 
recognizes the Mucin-like domain of Nfasc186, NFF-3 antibody recognizes 
the FnIIIC domain of Nfasc155 and NFC1 recognizes the C-terminus of all 
Neurofascins. 
B. Hindbrain tissue isolated from E15.5 and P60 animals were probed with 
different Neurofascin antibodies. NFC1 antibody recognized two strong 
bands at E15.5, the upper one is Nfasc186, and the bottom one is Nfasc140, 
the faint band in the middle is likely to be a non-specific band because it 
does not appear in postnatal tissues. At P60, NFC1 recognized Nfasc186 at 
the top, Nfasc155 in the middle and Nfasc140 at the bottom. MNF-2 
antibody recognized Nfasc186 only at E15.5 but an extra band appeared 
below Nfasc186 at P60, I think the extra band could be a degradation of 
Nfasc186 or non-specific band. NFF3 antibody did not detect anything from 
E15.5 lysate, because myelination is not started at this age; at P60 a single 
band Nfasc155 was detected by NFF3. Hence, MNF2 and NFF3 did not 
recognize Nfasc140. Only NFC1 can recognize Nfasc140. Here, all E15.5 
lanes loaded the same amount of protein from the same animal. And so did 
the P60 lanes. 
 
3.1.3 Nfasc140 is differentially expressed during CNS development 
Studies in the chick have shown that Nfasc166, which has a similar domain structure 
to Nfasc140, is only expressed at the embryonic stage in development (Hassel et al., 






that mouse Nfasc140 can also be detected in adult CNS lysates. To provide a better 
understanding of this age-related change in level, the expression pattern of Nfasc140 
was analyzed during mouse development. CNS lysates from wild type mice at 
different ages (E13, E15, P1, P4, P8, P12 and P45) were isolated and analyzed by 
Western blots using the NFC1 antibody. The results showed that the level of 
expression of Nfasc140 is high in the embryo but that it is down regulated at birth 
but expression then increases again after P8 (Fig. 24).  
 
Figure 24. Western blot results showing the expression pattern of Nfasc140 in 
CNS 
Whole head lysate at E13.5 and hindbrain lysates at all other ages were probed 
with NFC1 antibody. At E13 the predominant isoform is Nfasc140. And 
Nfasc140 expressing is high at E15. The level of expression of Nfasc140 was 
very low, barely detectable, from P1 to P8. From P8 Nfasc140 protein increased 
and reached a high level again at/before P45. Two whole mouse heads were 
used in the E13 lysate, two mouse hindbrains were used in E15 and one mouse 
hindbrain were used in the lysates of other ages. For each age, three animals 
(six animals at E13 and E15) were taken from different litters. And all three 
experiments showed the same expression pattern. Normalized with γ-Actin. 
 
Interestingly, Western blot using antibodies against myelin basic protein (MBP), a 
major component of mature myelin, showed that both Nfasc140 and MBP expression 
levels increase around P10, suggesting that Nfasc140 might be involved in early 





Figure 25. Nfasc140 and MBP expression levels increase at similar ages. 
Western blots using whole head lysate at E13.5 and hindbrain lysate at other 
ages. NFC1 antibody was used to show expression levels of Nfasc140 compared 
to Nfasc186 and Nfasc155 at different ages. Anti-MBP was used to indicate the 
onset of myelination. Two whole mouse heads were used in E13 lysate and one 
mouse hindbrain were used in the lysates of other ages. For each age, two 
animals (four animals at E13) were taken from different litters. And two 
experiments showed the same expression pattern. Nfasc186 is used as loading 
control except lane E13.5, at which age the Nfasc186 level is too low. 
 
 
3.1.4 Nfasc140 is differentially glycosylated 
Western blot analysis of WT adult hindbrain lysate using the NFC1 antibody 
revealed that the strong band, which runs at a similar mobility to Nfasc140, is a 
doublet (Fig. 26). Previous work (Volkmer et al., 1992, Davis et al., 1993, Maier et 
al., 2005 and Pomicter et al., 2010) has shown that Neurofascins are glycosylated. 
Since the hindbrain is made up of distinct structures, with differing roles, it is 
possible that post-translational modifications of Nfasc140 may be different according 
to the brain region. To examine this possibility, tissue lysates were collected from 
adult wild type pons and cerebellum. Interestingly, after separating hindbrain into 
cerebellum and pons, western blot analysis showed that the upper band of the doublet 
was enriched in the lysate of pons and the lower one was concentrated in the 
cerebellum lysate (Fig. 26A). To check whether the mobility difference was caused 
by differential glycosylation, tissues were deglycosylated by treating WT adult brain 
homogenates with PNGaseF. After deglycosylation, the tissue lysates of pons and 
cerebellum were run on western blot and probed with NFC1 antibody. Results 




deglycosylation (Fig. 26B). This strongly suggests that the doublet corresponds to 
differentially glycosylated Nfasc140 in different parts of the adult hindbrain. 
 
 
Figure 26. Nfasc140 in different tissues is differentially glycosylated 
A. Western blotting revealed that Nfasc140 in adult pons and cerebellum have 
different mobilities which accounted for the doublet in hindbrain lysate of 
adult mice.  
B. The Western blot showed that after PNGaseF treatment Nfasc140 in pons 
and cerebellum shifts to the same level.  
 
The two band pattern of Nfasc140 in adult is caused by differential glycosylation of 
Nfasc140 in different tissues. At the same time I wondered whether the mobility 
differences of Nfasc140 between E15.5 and P60 tissues were also caused by 
differential glycosylation. To explore the reason for difference, PNGaseF 
deglycosylation was repeated using brain lysates from E13 and P60 (Fig. 27). 
However the result did not resolve the question. After deglycosylation, unlike the 
P60 lysates, lysates from E13 showed a much wider and fuzzy band which ran 
slightly higher than Nfasc140 from adult on Western blot (Fig. 27). This fuzzy band 
could be caused by phosphorylation (Kizhatil et al., 2002) or any other post-
translational modifications of Nfasc140. Because the mobility of those bands in 
different ages were so similar, it was very unlikely there would be any domain 
difference between the bands of E13 tissues and adult tissues. I therefore 
hypothesized that the bands from E13 and P60 represented the same Nfasc140 







Figure 27. Deglycosylation on tissues from E13 and P60 
Before deglycosylation (control), Nfasc140 from E13 and P60 pons had the 
same size. After deglycosylation (PNGase F), Nfasc140 from E13 shifted down 
and became fuzzy, and it appeared to be bigger in size than Nfasc140 from P60. 
Experiment repeated three times with different digestion time and enzyme 
concentration, the same results were observed in all repeats.  
3.1.5 Nfasc140 is a neuronal protein 
My results so far have shown that Nfasc140 is an isoform of Neurofascin with a 
domain structure that differs from both neuronal Nfasc186 and glial Nfasc155. Next, 
I asked in which cell types Nfasc140 is expressed. Three different Cre mouse lines 
were used here to conditionally delete Neurofascins in different cells. 
 
First, to determine whether Nfasc140 is expressed by glial cells or neurons, a mouse 
line where Cre recombinase is driven by the 2 ,́ 3 -́cyclic nucleotide 3 -́
phosphodiesterase (CNP) promoter (Lappe-Siefke et al., 2003) was crossed with 
mice carrying Nfasc floxed alleles to generate mice in which Nfasc155 was 
specifically inactivated in glial cells (CNP-Cre/Nfasc
fl/fl
). These mice die around P17. 
Western blots using hindbrain lysates from these mice showed that at P4, a time 
when Nfasc155 is normally detected, Nfasc155 was no longer present, whereas 
Nfasc140 could still be detected (Fig. 28 left). These data support the hypothesis that 
Nfasc140 is a neuronal isoform. To exclude the possibility that Nfasc140 might have 
a lower turnover rate compared to Nfasc155, a tamoxifen inducible glial conditional 
knockout line was used. Mice carrying one Nfasc floxed allele and one null allele 
(Nfasc
fl/-
) were crossed with mice expressing Cre fused to the estrogen receptor 




(PLP) promoter (PLP-Cre ERT2). At P90, one month after tamoxifen treatment, 
Nfasc186 and Nfasc140 were still detectable by Western blotting whereas deletion of 





Figure 28. Nfasc140 is not expressed by glial cells. 
Western blot using NFC1 antibody showed only Nfasc155 was deleted in CNP-
Cre/Nfascfl/fl mouse at P4, whereas Nfasc186 and Nfasc140 are present (left). 
Nfasc155 was also undetectable in the inducible conditional PLP-
CreERT2/Nfascfl/- mice but Nfasc140 was still present (right). Two animals from 




These results indicated that Nfasc140 is not an oligodendroglial protein. To confirm 
that Nfasc140 is neuronal, mice expressing a tamoxifen inducible Cre driven by the 
neuronal Thy-1 promoter (Thy1-CreERT2) were crossed with mice carrying one 
Nfasc flox allele and one null allele (Nfasc
fl/-
) to inactivate Nfasc186 in neurons 
(Thy1-CreERT2/ Nfasc
fl/-
). Spinal cord lysates of control (Nfasc
fl/-
) and conditional 
Thy1-CreERT2/ Nfasc
fl/-
 mice 4.5 months post tamoxifen treatment were probed with 
the NFC1 antibody (Fig. 29). The major neuronal isoform, Nfasc186 was absent 
from tamoxifen treated conditional mutant mice and Nfasc140 was highly reduced, 
suggesting that Nfasc140 is present in neurons (Fig. 29). This also suggested that 





Figure 29. Nfasc140 is present in neurons. 
Western blot analysis using the NFC1 antibody showed that both Nfasc186 and 
Nfasc140 were highly reduced in adult Thy1-CreERT2/Nfascfl/fl mouse lysate at 
4.5 months after tamoxifen injection. Three animals from different litters were 
used. Normalization was using γ-Actin. Level of Nfasc140 in mutants was only 
0.39±0.11 times of Nfasc140 in WT. Relative density of protein samples was 
measured with ImageJ and adjusted according to the γ-Actin band density. 
(means ± SEM; n = 3 for each) 
 
3.1.6 Nfasc140 is highly concentrated in the developing cerebellum 
 
Since cellular migration is still occurring in the cerebellum at E13.5 and Western 
blots have shown that Nfasc140 is the predominate isoform of Neurofascins at this 
embryonic stage (Fig. 23), I examined the cellular location of Nfasc140 by 
immunofluorescence. NFC1 immunofluorescence staining is concentrated along the 
cerebral cortex and also inside the cerebellum at E13.5 (Fig. 30). By E15.5, very 
strong immunofluorescence staining of deep cerebellar nuclei in wild type animals 
was observed. Western blots of E15.5 hindbrain indicated that Nfasc186 is also 
present along with Nfasc140 at this stage of embryogenesis (Fig. 21). To determine 
which isoform is expressed at this stage in the developing cerebellum, I performed 
double staining using NFC1 and Nfasc186 specific antibodies. No 
immunofluorescent staining was present in the cerebellum of WT animals at E15.5 
using the Nfasc186-specific antibody alone (Fig. 21). This suggests that Nfasc140 is 

















Figure 30. Confocal imagines showing Neurofascin localization during 
embryogenesis. 
Fluorescent microscope images of sagittal sections of WT mouse embryos at 
the indicated ages were adapted from the Allen Brain Atlas 
(http://mouse.brain-map.org) to indicate the histological localization of the 
immunofluorescence. NFC1 antibody in red was used here to stain Neurofascin 
in the cerebellum and WT animals.  
At E13.5 Nfasc140 immunoflourescence was concentrated at the rhombic lip 
migratory stream (RLS) and nuclear transitory zone (NTZ) (white arrows). 
At E15.5 Neurofascins were concentrated in the developing deep cerebellar 
nuclei (white circle) and also almost the whole cerebellum has strong 
Neurofascin staining. Cerebellum from Neurofascin knockout animal at E15.5 
was used as a negative control. 
At E17.5 the Neurofascin signal decreased substantially and was concentrated 
at the external granular layer (white arrows). Scale bar 250 µm. (Negative 




Neurofascin knockout mice (Nfasc
-/-
) do not express any of the isoforms of 
Neurofascin and die in the early postnatal period (P7) (Sherman et al., 2005). To 
investigate potential function(s) of Nfasc140, Nfasc
-/-
 and WT brain slices were 
collected and stained with various antibodies to analyse possible differences between 





Nfasc140 appears to be concentrated at the nuclear transitory zone at E13.5 (Fig. 30), 
which eventually develops into the deep cerebellar nuclei at older age (E17.5). 
Previous studies have shown that Purkinje cell migration is not affected in Nfasc
-/-
 
mice at P6 (Zonta 2011). So, instead of Purkinje cells, the rhombic lip-derived cells 
which express the transcription factor Pax6 (Andrew et al., 2006) were studied. 
Pax6-positive cells are derived in the URL and migrate through RLS to NTZ (Fig. 
12). Immunofluorescent co-staining using antibodies against NFC1 and Pax6 showed 
clear Pax6-positive cells migrating from the URL, RLS and NTZ in both WT and 
Nfasc
-/-
mice at E15.5 (Fig. 31). Since there were no obvious differences in the 
number of Pax6-positive cells between Nfasc
-/-
 and WT mice at E15.5, cell migration 















Figure 31. Migration of rhombic lip-derived cells is unaffected in Neurofascin 
null embryos 
Confocal images of Sagittal sections of WT E15.5 cerebellum stained with NFC1, 
MNF2 and Pax6 antibodies. NFC1 antibody showed strong signal at the NTZ in 
WT animals; however no MNF2 (Nfasc186 specific Ab) co-staining was 
detected. These two observations suggest that Nfasc140, not Nfasc186, is 
present in the NTZ of the cerebellum. NFC1 and Pax6 co-staining showed clear 
Pax6 positive cells migrating from URL, RLS and NTZ in both WT and Nfasc-/-
mice indicating that the migration was not affected in Nfasc null mice. Scale bar 
200 µm. 
 
To confirm cells were migrating normally during later cerebellar development, brain 
slices from mutant and WT mice were collected at E17.5 and stained with Pax6 and 
NFC1 antibodies. Results were similar to those obtained at E13.5, with no difference 
in the distribution of Pax6-positive cells observed between Nfasc
-/-
 and WT mice (Fig. 
32), providing further support that cell migration is not altered when Neurofascin is 
absent.  
 
Therefore the functions of Nfasc140 at early development stages are still not clear. 






Figure 32. Pax6 positive cell migration is unaffected in Nfasc-/- mouse. 
Confocal images showed at E17.5 Neurofascin staining (NFC1) was faint and 
concentrated at the external granular layer (EGL which derived from RLS at 




which is derived from NTZ , the EGL and URL in both WT and Nfasc-/- mice. 
Scale bar 250 µm. 
3.1.7 Generation of a transgenic mouse line expressing Nfasc140-flag in vivo  
Since there are no unique domains to which it is possible to raise Nfasc140-specific 
antibodies, I decided to use transgenic mice to study the function of Nfasc140. A 
transgenic line (T140) was generated expressing full-length Nfasc140 with a FLAG 
tag at its C-terminus (Nfasc140-flag) under the control of the neuronal Thy-1 
promoter (Fig. 13). Western blot of T140 hindbrain lysates using two Neurofascin 
antibodies and Flag antibodies (anti-Flag) showed that Nfasc140-flag is expressed in 
vivo and the corresponding band has an electrophoretic mobility between 
endogenous Nfasc140 and Nfasc155 (Fig. 33).  
 
Figure 33. Western blot showing the expression of flag-tagged Nfasc140 in 
transgenic mouse brain. 
Western blot was performed on hindbrain lysates from T140 transgenics on a 
WT background at P30. NFC1 detects Nfasc186, Nfasc155 and a strong 140 kD 
band which corresponds to transgenic Nfasc140. NFF3, the Nfasc155-specific 
antibody, detected Nfasc155 only and anti-Flag detected he Nfasc140-flag band 




3.1.8 Nfasc140-flag is concentrated at nodes in both CNS and PNS 
Within the CNS and PNS, Nfasc186 is targeted to the nodes of Ranvier and 
Nfasc155 is targeted to the paranodal regions (Tait et al., 2000, Sherman et al., 2005, 
Zonta et al,. 2008 Zonta et al., 2011). I have established that, like Nfasc186, 
Nfasc140 is expressed in neurons (Fig. 28) but unlike Nfasc186, Nfasc140 lacks the 
Mucin and FNIII E domains (Fig. 21). The role of these domains in transportation 
and targeting of Neurofascins is still unclear, therefore I examined where transgenic 
Nfasc140 is targeted.  
 
Transgenic mouse tissues from the CNS and PNS at P30 were isolated, fixed and 
their fibres teased out. Immunofluorescence of teased fibres from sciatic nerves (PNS) 
and the ventral funiculus of the spinal cord (CNS) showed that Nfasc140-flag was 
targeted to nodes in both the PNS and CNS (Fig. 34). This indicates that the Mucin 
and FNIII E domains are not required for the transportation and targeting of 
Neurofascins. It was already known that transgenic Nfasc186 is targeted to nodes of 
Ranvier so transgenic Nfasc186 mice were used in my study as a comparison. 
 
Figure 34. Immunofluorescence showing Nfasc140-flag is targeted to the 
nodes of Ranvier. 
Confocal images of teased sciatic nerves (PNS) and ventral funiculus (CNS) were 
stained with antibodies against anti-Flag (Green) and Neurofascin (NFC1, red). 
Nfasc140-flag and Nfasc-186 are targeted at the nodes of Ranvier in both CNS 




3.1.9 Nfasc140-flag can be targeted to the AIS 
Previous studies showed that Nfasc186 is targeted to the axonal initial segment (AIS) 
(Hedstrom et al,. 2007, Zonta et al., 2011). Because Nfasc140 is neuronal and 
targeted to nodes, like Nfasc186, the ability of Nfasc140 to target to the AIS was 












 were stained with NFC1 and Flag antibodies. 
Immunofluorescent results showed that both transgenic animals have NFC1 and Flag 
staining at the AIS (Fig. 35). Since the transgenic animals were on an Nfasc-null 
background, the results indicated both Nfasc140-flag and Nfasc186-flag can be 
targeted to the AIS. Also the Nfasc140 and Nfasc186 are also targeted to the plasma 





Figure 35. Immunofluorescence showing Nfasc140-flag and Nfasc186-flag are 
targeted to the AIS. 




NFC1 and Flag antibodies stained the Nfasc140-flag at AIS in T140/Nfasc-/- mice 
and Nfasc186-flag in T186/Nfasc-/- animals at the age of P8. Scale bar, 10 μm. 
 
It has recently been shown that Nfasc186 plays an important role in maintaining the 
integrity of the AIS in adult animals (Zonta et al., 2011). To determine whether 
Nfasc140 or Nfasc186 alone persist at the AIS and maintain the protein structure of 
the AIS, older mice (P60) were sacrificed, their cerebella isolated and 
immunofluorescent staining conducted. Both Nfasc140-flag and Nfasc186-flag were 
still targeted at the AIS, suggesting that the flag tag does not interfere with targeting 
and maintenance of the 2 isoforms of Neurofascins. Furthermore, these data also 
suggest that the Mucin and FNIII E domains of Nfasc186 are not involved in the 
targeting of Neurofascins to the AIS, as Nfasc140-flag is still targeted to the AIS (Fig. 
35). 
3.1.10 The level of expression of Nfasc140-flag and Nfasc186-flag are higher than 
the level of endogenous Neurofascins.  
The function of Nfasc186 has been studied (Zonta et al,. 2008; Zonta et al., 2011). 
Nfasc140 was been shown to have many similar characteristics compared to 
Nfasc186, since they are both expressed in neurons and are both targeted to the nodes 
and AIS (Fig 27, 28, 33 and 34). Because the transgenic Nfasc140-flag and 
Nfasc186-flag have a very different promoter from the endogenous Nfasc140 and 
Nfasc186, to further understand Nfasc140-flag and Nfasc186-flag, the levels of 
expression of Neurofascins were examined and compared with the endogenous ones. 
Western blots showed that both transgenic proteins were over-expressed under the 







Figure 36. Western blot showed Nfasc140-flag and Nfasc186 are both over 
expressed comparing with WT 
Hindbrain lysates from WT, T140/Nfasc-/- and T186/Nfasc-/- mice were blotted 
with NFC1 antibody. The Nfasc140-flag band and Nfasc186-flag band had 
stronger signal intensities than the endogenous protein indicating they were 
over expressed in transgenic animals. The flag tagged Nfasc140 and Nfasc186 
are larger than the endogenous proteins, due to the addition of the flag tag.  
 
The results showing the level of expression of Nfasc140-flag was 2.25 ± 0.3 
times more than endogenous Nfasc186. And Nfasc186-flag was 1.77±0.2 times 
more than endogenous Nfasc140. And Nfasc186-flag is 1.03 ± 0.2 times of 
Nfasc140-flag. Relative density of samples were measured with ImageJ and 
adjusted according to the γ-Actin band density. (means ± SEM; n = 3 for each) 
Normalized with γ-Actin. 
 
3.1.11 Nfasc140-flag can rescue the nodal complex in both CNS and PNS 
Both Nfasc186 and Nfasc155 have important roles regarding the nodal and paranodal 
protein organization at the nodes of Ranvier. In Neurofascin knockout mice the nodal 
components are missing from the nodal area in both PNS and CNS (Fig. 37) 
(Sherman et al., 2005, Zonta et al., 2008). Expression of Nfasc186 in neurons can 
rescue the nodal complex in both PNS and CNS on an Nfasc
-/-
 background. And the 
expression of Nfasc155 rescues the CNS nodal complex (Zonta et al., 2008). 
Meanwhile, we have found that the Nfasc140-flag was able to target to the nodes. 






Figure 37. Nodal components were mislocalized in Nfasc-/- mouse (Sherman 
et al., 2005, Zonta et al., 2008) 
Confocal images showed in Nfasc-/- animals Nav, NrCam, AnkyrinG and βIV-
Spectrin, are mislocalized from the nodes in PNS (A). The nodal components, 












fibres from both PNS and CNS were stained with various antibodies. Meanwhile, 




) were also used 
as a comparison in order to further understand any differences between Nfasc140 and 
Nfas186 in their ability to cluster nodal components.  
 
Immunofluorescence showed that Nfasc140-flag and Nfasc186-flag were both 
capable of reconstituting the nodal complex (Fig. 38). When either Nfasc140-flag or 
Nfasc186-flag were present at the nodes, Nav channels were targeted to the nodes. 
Hence, Nfasc140-flag and Nfasc186-flag have the same ability to organise the nodes 
of Ranvier. Moreover, that fact that Nfasc140, lacking the Mucin and FNIIIE 
domains, could also recruit βIV-Spectrin, AnkyrinG, NrCam (PNS), Gliomedin 
(PNS) and Brevican (CNS) to the node, indicated that those two domains are 











Figure 38. Nodal components of the PNS and CNS are rescued by Nfasc140-
flag and Nfasc186-flag. 
Immunostaining of teased quadriceps fibres (PNS) at P60 shows that when 
either FLAG-tagged Nfasc140 or Nfasc186 are expressed on a Nfasc-/- 
background they can bring back the nodal components, Nav, ankyrinG, 
βIVspectrin, NrCAM and gliomedin. Meanwhile, in the Nav/Kv1.1/NFC1 triple 
staining panel, because the transgenic does not have Nfasc155, the Nav (green) 
relocalized next to the Kv1.1 (gray) without NFC1 (red) in the middle. This 
suggested the rescue of the node was not accompanied by reformation of the 
axoglial junction and, as a consequence, juxtaparanodal Kv1.1 channels were 
mislocalized when compared to WT.  
 
Similarly, Immunostaining of spinal cord ventral funiculus fibers (CNS) at P60 
shows that both FLAG-tagged Nfasc140 and Nfasc186 can rescue the nodal 
components, Nav, AnkyrinG, βIVspectrin and Brevican when expressed on a 
Neurofascin-null background. As for the PNS, juxtaparanodal Kv1.1 were 





3.1.12 Expression of Nfasc140-flag or Nfasc186-flag partially restores nerve 
function 
Nfasc155 is an indispensable component of the Nfasc155-Caspr-Contactin adhesion 
complex at the paranode. Here two different transgenic animals were shown which 
lacked Nfasc155 and the paranodal adhesion complex. From the triple staining of 
Nav channel, Kv channel and NFC1, it was clear that the absence of Nfasc155 
resulted in a missing barrier between Nav channels and Kv channels. This presumably 
contributes to the reduction of the nerve conduction velocity shown below (Fig. 39).  
 
These transgenic animals started to show signs of neurological defects from P20, 
including tremors, weak hindlimbs and hindlimb clasping. Even though the 
hindlimbs were obviously abnormal, however, in the lab environment both of the 





of each were kept in animal units feeding for one year and then sacrificed.). 
 
Some ectopic expression of both Nfasc140-flag and Nfasc186-flag can be seen along 
the axons, which was not observed in WT animals (see Fig. 38 above). This might be 
caused by the over expression of both transgenic proteins under the control of Thy-1 
promoter. It is unclear whether this ectopic protein expression would affect nerve 
function. However, Caspr-null mice have very similar reductions in nerve conduction 
velocity, suggesting that the decreased rates observed in the transgenics are due to 
disrupted paranodal axo-glial junctions (Diane Sherman, personal communication). 
 
Furthermore, studies on contactin knockout mouse (Boyle et al., 2001) showed that 
when contactin was deleted, Caspr ,but not Nfasc155, was mislocalized, which led to 
a shift of Kv channels from juxtaparanodal region towards the paranodal region of the 
septate-like junctions at the paranodes of PNS fibres, and nerve conduction velocity 















Figure 39. Nerve conduction velocity is partially rescued in transgenic 
animals. 
A. The wave shape of the CAP of both WT and T140/Nfasc-/- are shown here, 
their shapes were very similar. CAP of T186/Nfasc-/- is almost the same as 
T140/Nfasc-/-, which was not showing here. 
B. The data of one quadriceps nerve from each WT and T140/Nfasc-/- is 
plotted on the chart. The conduction velocity is calculated as the slope of 
the trend line. The same method was used to calculate the conduction 
velocity of nerve from T186/Nfasc-/-. 
C. Data comes from Sherman et al., 2005. In Neurofascin transgenic animals, 
the conduction velocities of mutant peripheral sciatic nerves were 
drastically reduced from 3.7 ± 0.5 m/s (WT, Nfas+/+) to 0.7 ± 0.2 m/s 
(Nfasc−/−) (means ± SEM; n = 3 for each). 
D. Quadriceps nerves from P60 animals was used to measure the nerve 
conduction velocity. The conduction velocities are: 41.20 ± 1.64 m/s for WT, 
24.13±2.32 for T140/Nfasc-/- and 23.02±1.42 for T186/Nfasc-/- animals. The 
conduction velocity of WT animals is almost twice of the transgenic 
animals. There was no significant difference between the two transgenic 
lines. Values are means ± SEM; n=6 mice for each condition; ∗∗∗, p <0.0001, 
one way ANOVA test is followed by Tukey's Multiple Comparison Test. 
 





) was recorded and the conduction velocity of nerves was calculated 
using the distance divided by the latency (Fig. 39 A and B). To compare the shape of 





WT and mutant, to ensure the duration of the CAP were similar. From the picture 
and the other CAP waves which I measured, I have the impression the potential 
difference is smaller in mutant comparing with WT. Because the voltage of the 
stimulations in my experiments is different between measurements, further study 
using similar stimulations is needed to confirm the existence of the differences.  
 
Nerve conduction velocity analysis showed the nerve conduction velocity dropped 
from 41 to 23-24 m/s, this confirmed an almost 50% conduction velocity reduction in 
the transgenic animals (Fig. 39 D). However, this compares with an over 80% 
reduction in the peripheral nerves of mice lacking both paranodal junctions and 
Nfasc186 (Sherman et al. 2005) (Fig. 39 C). The faster nerve conduction velocity in 
transgenic animals comparing with Nfasc-null animals is likely to be the result of the 




 animals. Because in 
those animals the Nav is concentrated at the nodes (Fig. 38); meanwhile, in Nfasc-
null the Nav is no longer targeted at nodes (Fig. 37). 
 
Since the nerve conduction velocity was reduced by half in the transgenic animals, I 
determined if this would affect behaviour. The Rotarod was used here to analyse 
motor behaviour. Rotarod is a motor coordination test; however, in our animal model 
both the CNS and PNS are likely to malfunction. Hence our result was not an index 
of the motor neuron dysfunction but a quantifiable way of evaluating how worse the 
transgenic animals performed in a behavioural task. And the performance of the 
transgenic animals clearly showed they were worse than the wild type animal (Fig. 








Figure 40. The transgenic animals have motor behavioural dysfunction.  
T140/Nfasc-/- and T186/Nfasc-/- P60 animals were significantly worse than WT 
animals on the Rotarod. And the deficit comparing the two different 
transgenice animals was not significantly different. Values are means ± SEM 
where n=6 mice for each condition. ∗∗∗, p <0.0001, one way ANOVA test is 
followed by Tukey's Multiple Comparison Test. 
 
3.1.13 Summary of the first part of my study. 
A third isoform of Neurofascin, Nfasc140, has been characterized in this study. By 
RT-PCR and DNA sequencing, I confirmed the amino acid sequence of Nfasc140. 
By comparing its sequence with Nfasc186 and Nfasc155, the domain structure of 
Nfasc140 was shown. Nfasc140 has the domains common to all known Neurofascins, 
it contains six IgG domains, A, B and D FnIII domains, the transmembrane region 
and the cytoplasmic domain.  
 
The domain composition of Nfasc140 is almost identical to that of Nfasc166 in chick. 
It has been shown that Nfasc166 is predominantly expressed in dorsal root ganglia 
from E5 to E8 in chick and the level of expression decreases afterwards (Koticha et 
al., 2005). I found Nfasc140, like Nfasc166, is highly expressed at the early 

















Conditional deletion of Neurofascins in glial or neuronal cells revealed that Nfasc140 
is expressed in neurons. When the Neurofascins are deleted from the nodes, neuronal 
proteins like AnkyrinG, NrCAM, Brevican and Gliomedin are no longer targeted to 
the nodes (Sherman et al., 2005, Zonta et al., 2008). This led me to compare the other 
neuronal Neurofascin, Nfasc186, with Nfasc140. The results showed that Nfasc140 
alone, like Nfasc186, can recruit the nodal proteins to the nodes of Ranvier in both 
PNS and CNS.  
 
3.2 Intact paranodal axoglial junctions can cluster Nav 
channels in the absence of neuronal Neurofascin 
 
In this second part, in order to explore the function of Nfasc155-Caspr-Contactin 
complex during the formation of nodes of Ranvier, especially to further explore the 
controversial relationship between the paranodal complex and Nav clustering at the 
nodes, I intended to generate a transgenic line in which Nfasc186 could be deleted at 
a very early development stage. This would allow me to determine whether Nfasc155 
and the axoglial junction alone can promote the clustering of Nav at the nodes. 
3.2.1 Generation of early deletion of Neuronal Neurofascins animals 
In order to clarify the function of neuronal Neurofascins and how Nav channels are 
targeted initially to the node, I generated a neuronal Cre-expressing line in which the 
Cre was expressed at an early age. In this mouse line the Cre recombinase is driven 
by the thymus cell antigen 1 (Thy-1) promoter and this was crossed with mice 
carrying Nfasc floxed alleles to generate mice in which Neurofascins were 
specifically inactivated in neuronal cells at an early development stage (Thy-
Cre/Nfasc
fl/fl
). In these studies Nfasc155 should continue to be expressed under the 
control of its normal promoter in myelin-forming glia.  
 
I intended to generate a mouse model which can abolish neuronal Neurofascin 




needed to be activated before Nav channel targeting and also have a high efficiency 
to delete the Neurofascins.  
 
To check the age of Cre activation and the efficiency of Cre penetration in CNS, the 
expression levels of neuronal Neurofascins in spinal cord tissues at different ages 
were checked using NFC-1 antibodies. As the result showed, the Cre started to 
inactivate neuronal Neurofascin expression before E15 and at E18 the neuronal 
Neurofascins were undetectable by western blot (Fig. 41). 
 
In the CNS, clustering of Nav channels depends on specific axoglial contact 
(Rasband et al.,1999) . Previous studies have indicated that myelination in ventral 
spinal cord starts at E18, one day before birth (Foran et al., 1992). Moreover, our 
own studies on the cervical spinal cord show that at P3 nodes are undetectable by 
sodium channel staining (unpublished). So when neuronal Neurofascins were deleted 
at E18 the sodium channels were not yet clustered. Hence, our transgenic animal line 
fulfils the criteria for our experimental purpose.  
 
Figure 41. Nfasc186 is deleted from CNS from E18. 
Western blots of spinal cords from different ages showed at E15 Nfasc186 was 
partially deleted. And from E18 to P8 Nfasc186 was undetectable by western 





The western blot at P8 (Fig. 41) showed when Nfasc186 was deleted Nfasc155 was 
also slightly reduced. This may reflect a slight delay of Nfasc155 expression after 
deleting neuronal Neurofascins. This was suggested by the observation of Nfasc155 
expression patterns in different ages in PNS sections (Fig. 42).  
 
In order to examine Cre expression in PNS, sections of quadriceps femoral nerves 
from P1-P5 animals were used for immunostaining. Results showed at P3, when 
Neurofascins had located at both nodes and paranodes in wild type animals, there 
was almost no Neurofascin staining in transgenic animals (Fig. 42 A). This indicated 
that Cre is active in neurons. Although Nfasc155 appearance at paranodes was 
delayed in the transgenic mouse at P6, Nfasc155 appeared at many paranodes, and at 
the same time Nav channel staining was observed.. The delay in the expression of 
Nfasc155 might be caused by a delayed myelination. To examine this possibility, 
sections from P3 when there were very few Nfasc155 positive paranodes were 
stained with MAG antibodies. Results showed the MAG staining was very similar in 
both WT and transgenic mice, so the myelination had occurred in both control and 
transgenic animals (Fig. 42 B). Hence, the later appearance of Nfasc155 was unlikely 
caused by impeded myelination. Hence, the delayed appearance of Nfasc155 is likely 
to reflect a delayed localization or expression of Nfasc155 itself. How Nfasc186 
might influence Nfasc155 localization or expression is unknown.  
 
Importantly, at P3 there was little Nfasc186 staining in the nerve sections and by P6 
the Nfasc186 was missing from most of the nodes (Fig. 42 C). This suggested that 
Nfasc186 is deleted before the clustering of Nav channels occur at nodes of Ranvier. 
The results also showed that at P3 there were Nav channels positive nodes without 
neuronal Neurofascin. This supports the view that paranodal junctions can cluster 

















Figure 42. Nfasc155 expression is delayed in Thy-Cre/Nfascfl/fl animals. 
A. P3 PNS nerve sections showing Neurofascins detected by NFC1 antibody in 
WT. Neither Nfasc155 nor Nfasc186 positive nodes were present. 
B. MAG staining in red showed axons at P3 were myelinated in both WT and 
transgenic animals. 
C. At P6 Nav channels were targeted at the nodes in the transgenic animals 
and Nfasc155 positive paranodes flanked the Nav channels. Scale bar 15 
μm. 
 
3.2.2 Clustering of Nav channels does not require neuronal Neurofascins. 
To investigate the effect of Nfasc186 loss on Nav channel targeting to the nodes, 
quantitative studies were done on P5 - P6 Thy-Cre/Nfasc
fl/fl
 animals. Results showed 
that while less than 1% of the nodes have Nfasc186, more than 90% of the nodes still 
have Nav channels in CNS (Fig. 43). The high percentage of nodes which had Nav 
channels without Nfasc186 showed that the clustering of Nav channels is not 




that Nav channels clustering did not happen in the Nfasc-null mouse, which showed 
that Neurofascins are indispensable for Nav channel targeting to the nodes. In my 
study the high percentage of Nav channels targeting to the nodes showed that the 
paranodal junction can cluster Nav channels in the CNS. This confirmed previous 
observations that the clustering of Nav channels in CNS does not require neuronal 
Neurofascins (Zonta et al., 2008, Rasband et al., 1999).  
 
After the deletion of Nfasc186 from CNS nodes of Ranvier, its extracellular domain 
binding partner, Brevican (Hedstrom et al., 2007), was missing from the nodal area, 
but other major nodal components, like AnkyrinG and βIV-Spectrin, were still 





















Figure 43. Nav channel targeting without neuronal Neurofascins in CNS at P6 
Immunoflorescence images of teased fibres from the ventral funiculus of the 
spinal cord in the CNS showed Nfasc186 and Brevican were not detected at the 
nodes at P6. Quantitation of the percentage of Nfasc186 positive nodes 
showed there was less than 1% Nfasc186 positive nodes left; meanwhile, 
quantitation of the Nav positive nodes showed more than 90% nodes were 
targeted at the nodes of Ranvier. NFC1 recognises all forms of Neurofascin. 
Values are means ± SEM where n=3 mice for each condition. Scale bar 2 μm. 
 
Similar results were observed in the PNS (Fig. 44). After the ablation of neuronal 
Neurofascins, the sodium channels could still target to the nodes. This finding 





, which had a truncated form of Nfasc155 expressed in the 
glial cells on a Nfasc-null background, were used to address the question whether 
Nfasc155 alone could rescue Nav channel clustering. They showed that when only 
the truncated form of Nfasc155 was expressed, no Nav channel was clustered at the 
nodes in PNS. It seems likely that the cytoplasmic tail might have a key role in 
clustering Nav channels; it is also possible that the plp promoter used might drive the 
truncated Nfasc155 expressing at a late time point which subsequently affects the 



























Gliomedin which interacts with Nfasc186 at the node in the PNS was not targeted to 
the node, but other nodal proteins were targeted to the nodes. Nevertheless, the levels 
of expression of nodal proteins appeared to be lower than in the control group. This 












Figure 44. Nav channel targeting without neuronal Neurofascins in PNS at P6 
Immunoflorescence images of teased fibres of PNS showed that Nfasc186, 
NrCAM and Gliomedin were not detected at the nodes at P6. Quantitation of 
the percentage of Nfasc186 positive nodes showed that there were less than 
3% Nfasc186 positive nodes left; quantitation of the Nav positive nodes showed 
more than 80% nodes were targeted at the nodes of Ranvier. n=2 mice for each 
condition. Scale bar, 2 μm 
3.2.3 Summary of the first part of my study. 
A new neuronal Cre deletion mouse model was crossed with Nfasc
fl/fl
 mice to 
generate Tcre/Nfasc
fl/fl
,mice. So all the data above were gathered from animals on a 
CBA/C57 mixed background (F3 generation backcross to C57). At the F3 generation, 
neuronal Neurofascins, Nfasc186 and Nfasc140 were deleted as early as E18 in the 
CNS, before the start of myelination. In the PNS at P3, immunolabeling clearly 
showed Nfasc186 was not expressed in axons; surprisingly Nfasc155 was barely 
detectable and only very few Nav channel-positive nodes were detected. However, at 
P6 many more Nav channel-positive nodes and Nfasc155-positive paranodes 
appeared. This indicates a delayed targeting or expression of Nfasc155 in the absence 
of neuronal Neurofascins at an early age (before P3). Also because the appearance of 


























P3 to P6. It indicates that the clustering of Nav channels can be promoted by 
paranodal junctions.  
 
Immunolabeling at P6 showed that less than 5% of the nodes have neuronal 
Neurofascins staining in either the PNS or CNS. However, more than 80% of the 
nodes in the PNS and more than 90% of CNS nodes have Nav channels. This 
supports the view that Nav channels can be clustered to the nodes of Ranvier by 
paranodal axoglial junctions only. In these experiments, only those nodes flanked 
symmetrically by Nfasc155 were counted. Some nodes only had Nfasc155 at one 
side, which may reflect the delayed expression of Nfasc155. And for some of those 
asymmetrical nodes, Nav channels are also found targeted to the nodal area, next to 
Nfasc155 staining (data not shown).  
 
3.2.3 The phenotypes changing from F3 to F6 
When we generate Thy-Cre animals, we used CBA and C57 hybrid eggs to getting 
more fertilized eggs for micro injection and a better pregnancy rate. In order to 
eliminate the variations of the strain background I decided to backcross animals and 
put Thy-Cre/Nfasc
fl/fl
 on a C57 background (F6 generation 98.375% congenic). 
Interestingly in F6 generation the phenotypes of the animals changed, the glial cells 
did not express Nfasc155 early in either PNS or CNS at P6 (Fig. 45). Also those 










Figure 45. Nfasc155 is not expressed in F6 animals at P6 
Western blot of quadriceps nerve and spinal cord tissues from F6 P6 animals 
showed that both Nfasc186 and Nfasc155 were deleted from Thy-Cre/Nfascfl/fl 
animals. Normalized with γ-Actin. And immunoflorescent staining confirmed 
the ablation of Nfasc186 and Nfasc155 from the nodes of Ranvier in F6 P6 
animals. . Scale bar, 2 μm 
 
The Thy-1.2 promoter was shown to be able to drive the expression of Cre in non-
neuronal tissues (Campsall et al., 2002). So loss of Nfasc155 might have been due to 
the fact that Cre was active in the glial cells on a C57 background, in this case it 
would delete all the Nfasc155 from glial cells. So we decided to check whether the 
change of background could cause the Cre to be expressed in glial cells and 
subsequently cause the ablation of the Nfasc gene and the Nfasc155 mRNA in glial 
cells. Hence, I checked Nfasc155 mRNA levels in peripheral nerves by semi-
quantitative PCR. These should contain no neuronal mRNAs. Quadriceps nerves and 
the femoral branches from both WT and Thy-Cre/Nfasc
fl/fl




was extracted. RT-PCRs with different numbers of cycles were shown below. 
Because there were no obvious differences between the expression levels of mRNA 
in WT and transgenic animals (Fig. 46), it was unlikely the Cre was active in the 
Schwann cells.  
 
 
Figure 46. mRNA level of Nfasc155 is not altered in Thy-Cre/Nfascfl/fl mice. 
Semi-quantitative RT-PCR was performed to amplify Nfasc155mRNA. The levels 
of mRNA were not reduced in transgenic animals. Normalized with 




4. Conclusions and Discussion 
4.1 OVERVIEW 
A fully developed node of Ranvier permits the rapid propagation of action potentials 
in myelinated axons, this is critical for the function of the vertebrate nervous system. 
 
Recently, there has been tremendous progress in our understanding of the events 
leading to the organization of the node and its environs along myelinated axons of 
the PNS and CNS. It has become increasingly clear that Neurofascins play a role in 
the localization of different channels in axons and that are required to establish 
saltatory conduction (Davis et al., 1993, Tait et al., 2000, Sherman et al., 2005, 
Burkarth et al., 2007, Zonta et al., 2008, Kriebel et al., 2011, Zonta et al., 2011). 
 
Previous studies on two major isoforms of Neurofascins, Nfasc155 and Nfasc186, 
have shown they are functionally different and each of them has distinct roles in the 
nodal formation. A third isoform, Nfasc140, was also described by the group of Dr V. 
Bennett in 1995. I identified the protein domain composition of Nfasc140; using a 
transgenic approach I am able to characterize the possible functions of Nfasc140 in 
vivo. Here I will discuss and validate my data on my study of Nfasc140.  
 
Even though the protein organizations at the nodes of Ranvier become more and 
more clear, the role of paranodal complex in clustering of nodes is still controversial. 
Two studies have showed that the targeting of Nav channels to the mature nodes of 
Ranvier can occur independently of the expression of Nfasc186 (or Neuronal 
Neurofascins) (Zonta et al., 2008; Feinberg et al., 2011). However, in another study, 
Nfasc186 has been showed to be indispensable for the targeting of Nav channels to 
the nodes of Ranvier and paranodes could not substitute (Thaxton et al., 2011). I 
generated Thy-Cre/Nfasc
fl/fl
 mouse line, which allows me to clarify the controversial 
theories. I found evidence showing the paranodal complex can target Nav to the 
nodal area. Here, I will discuss my results and the differences comparing with other 




4.2 Study of Nfasc140 
4.2.1 Domain composition of Nfasc140 
Western blot (Fig. 24, 25) result of the expression pattern of Nfasc140 showed the 
protein is highly expressed at embryonic stages, and is the predominate isoform of 
Neurofascin at the age of E13. Meanwhile, full length RT-PCR results revealed that 
at the age of both E13 (data not show) and E15 (Fig. 21) only one band was 
amplified and the sequencing results showed it is an isoform of Neurofascin which is 
smaller in size than Nfasc155. I think the amplified cDNA and the 140kD protein 
band detected on western blot is associated for four reasons. First, the estimated 
protein size based on RT-PCR and sequencing result is very similar to the Nfasc140 
protein band on Western blot. Second, the appearing of only one band at E13 in both 
Western blot and one product of RT-PCR has been found at E13. Third, using one 
pan Neurofascin antibody and two isoform specific antibodies to probe the Nfasc140 
protein on western blot, it confirmed the protein band on western blot has the same 
domains composition as the domains structure predicted by RT-PCR and sequencing 
result. Last, an adding or lacking of other domain will lead to an obvious change on 
protein size, which is unlikely happened in this case. So I think the association 
between cDNA and protein bands is well established here. To further confirm the 
protein sequence, protein sequencing can be conducted, Nfasc140 can be purified 
from animal brain tissue and digested into small pieces and subsequently sent to 
sequence. However, it would be very challenging to sequence the whole Nfasc140 
protein. Because Nfasc140 has more than one thousand amino acids, that is very long 
for protein sequencing, and it is also not easy to purify Nfasc140 from animal brains 
using the anti-peptide antibody we have. While all the results were very convincing, I 
think it is unnecessary to sequence the whole Nfasc140 protein in my study. 
 
Using primers to amplify all isoforms of transcripts of Neurofascin, at the age of 
E13.3 when only one isoform of Neurofascin was detectable by western blot, one 
cDNA was amplified (Fig. 21, 24). Using the same primers, when more than one 
isoforms of Neurofascin were detected on western bolt at the ages of E15.5, P17 and 




amplified instead of multiple products could be caused by the mRNA concentration 
differences among tissues from different ages, therefore, only the isoform which has 
the highest mRNA concentration in the tissue at a specific age was preferably 
amplified under the RT-PCR condition. In other experiment, different PCR primers 
which only amplify a small segment of Neurofascin can yield more than one bands 
from the mRNA (cNDA) extract from P17 and P30 animals which indicates the 
transcripts of other isoforms of Neurofascin is also presented in animals brain tissues 
when multiple protein bands were detected on western blots. 
 
The domain composition of Nfasc140 was determined by using three different 
Neurofascin antibodies to probe the Nfasc140 band on western blots. And the results 
demonstrated that Nfasc140 has no specific domains comparing with Nfasc186 and 
Nfasc155 (Fig. 23). Among those western blots, besides the three Neurofascins there 
were some uncharacterized bands, I will discuss them here. In the blot probed by 
NFC1 antibody, a faint band appearing above the Nfasc140 band in the lane of E15.5 
is a non-specific band. Because in previous studies the same band was also detected 
from Neurofascin knockout animal tissues at E15.5. Meanwhile, a band was detected 
by both NFC1 and MNF2 below the Nfasc186 band in the lane of P60. Which I think 
is a break down products of Nfasc186 in old animal tissues. Because a band at 
similar size was also found in the transgenic animal in which only Nfasc186-flag was 
expressed (T186/Nfasc
-/-
) (Fig. 37), and also it could be recognized by two different 
antibodies (Fig. 23). Due to the limited time for my study, I did not continue to 
characterize those proteins in my study. 
 
The domain composition of Nfasc140 is very similar to Nfasc166, and it has been 
shown that Nfasc166 interacts with NF166-axonin-1 and increases neurite outgrowth 
(Koticha et al., 2005, Pruss et al., 2009). This suggested Nfasc140 could have a 
similar role in regulating neurite extension and outgrowth in mouse. All these neurite 
outgrowth experiments were based on in vitro studies which have their limitations. It 
is known that the cell environment and cell-cell interactions in vitro differ from in 
vivo. In my study, I wanted to use in vivo system to answer this question, but I found 




neurite outgrowth in vivo, so I’ve checked the gross brain size and cortex thickness 
of control and transgenic animals but no obvious difference were found. Meanwhile, 
it is suggested Nfasc186 which has the Mucin like domain which can depress the 
neurite outgrowth. But when comparing the transgenic mice which only Nfasc140 or 
Nfasc186 was expressed, I did not find any obvious difference between brain size 
and cortex thickness. So I did not conduct further experiments to characterize the 
possible roles for Nfasc140 related to neurite outgrowth. Hence whether Nfasc140 
has a role in regulating neurite outgrowth in vivo is unclear, further studies are 
needed to answer this question. 
 
4.2.2 Nfasc140 is differentially expressed during CNS development 
Like the embryonic isoform Nfasc166 in chick, Nfasc140 is highly expressed at early 
embryonic stages. Also Nfasc140 is the predominate isoform in WT murine brain at 
E13 and E15 (Fig. 24). Interestingly, in contrast to Nfasc166 in chick, the expression 
level of Nfasc140 is up-regulated at later ages, around P12, which interestingly 
correlates with increasing MBP expression. Meanwhile, in the paper of Pomicter et 
al. (2010) they found a Neurofascin isoform (Nfasc155L) , which has a size similar 
to Nfasc140 is altered in multiple sclerosis plaque tissues. These observations 
suggest a possible role of Nfasc140 in myelination. However, in the study of 
Pomicter et al. they claimed the protein at the size of 140kD is a glial isoform after 
finding the protein was deleted from spinal card of glial specific Neurofascin knock 
out animals at P16. I think at the age of P16, the 140kD protein level in their control 
is very low (in my study the Nfasc140 also appears as a faint band at the age of P14 
(Fig. 24)), and the glial specific Neurofascin knock out animals are smaller and sick 
comparing with control at the age of P16. Hence the lower expression level and the 
bad state of animals might be the reasons that the 140kD band was undetectable in 
the study of Pomicter et al. rather than because the protein is deleted from the 
animals. To study this, brain tissues from MS patient and animals can be run on a 
western blot side by side and probed with Neurofascin antibody to confirm whether 
the 140kD band described by Pomicter et al. is correspond to Nfasc140 isoform. And 
also one can check the changes of the expression level of Nfasc140 in plaque tissues 




models can be used to check whether the change is related to the changes in 
myelination states.  
 
4.2.3 Nfasc140 is differentially glycosylated 
Nfasc140 is differentially phosphorylated in pons and cerebellum of murine brains 
(Fig. 26). Reversible phosphorylation often results in a conformational change in the 
structures of enzymes and receptors, which can activate or inhibit the enzymes and 
receptors. We know Neurofascin are CAMs and Nfasc140 isoform can help the 
targeting of nodal proteins like NrCAM, Gliomedin and Brevican. However, there is 
no evidence that Nfasc140 can regulate their expression levels, for example, NrCAM 
is still expressed and the level of expression is not changed in Neurofascin knockout 
mice observed by Sherman et al. (2005). It is possible that through phosphorylation 
the interaction between Nfasc140 and AnkyrinG is altered, which is suggested by the 
observation that the phosphorylated FIGQY motif of Neurofascin is able to bind to 
AnkyrinG (Kriebel et al., 2012) and Nfasc140 has the same FIGQY motif as the 
Neurofascin used in the study of Kriebel et al.. But the reason for the differential 
phosphorylation of Nfasc140 in different parts of brain is still unclear.  
 
4.2.4 Nfasc140 is a neuronal protein 
In CNP-Cre/Nfasc
fl/fl 
animals, Nfasc140 is still presented when Nfasc155 is deleted 
from the murine brain lysates (Fig. 28 left). In PLP-CreERT2/ Nfasc
fl/fl
 animals there 
was still a trace of Nfasc155 detected on western blot. Because the animals were sick, 
we did not keep them longer before all the Nfasc155 got deleted. Meanwhile, the 
Nfasc186 seems to be stronger this could be caused by the fact that the Nfasc186 
band is at the top of SDS-page gel, which means the proteins have not been separated 
well enough, this could lead to an artificial difference. The same samples were used 
for more than 3 repeats, but the Nfasc186 bands always looked different between 
WT and PLP-CreERT2/ Nfasc
fl/fl
. The Nfasc140 band is still clearly showed on the 
western blot (Fig. 28 right). The intensity of the Nfasc140 band looks reduced but it 
is clear the change of expression of Nfasc140 is not as affected as Nfasc155. Because 




the presence of Nfasc140, I think it is clear that Nfasc140 is not a glial isoform of 
Neurofascin. Transgenic line, Thy1-CreER2T/ Nfasc
fl/fl
, was used to check whether 
Nfasc140 is a neuronal isoform. Results showed when neuronal Nfasc186 is deleted 
in adult tissue, Nfasc140 is highly reduced (Fig. 29). There was a light band of 
Nfasc140 still present on the western blot. This could suggest that Nfasc140 has a 
lower turnover rate than Nfasc186. I think by using all three different lines, it is 
sufficient to prove Nfasc140 is a neuronal isoform of Neurofascin. To further 
confirm this conclusion, more experiments can be added, For example, neurons and 
glial cells can be cultured separately and western bolt of only neuron or glial cells 
can show the different composition of Neurofascin isoforms in different cell types.  
 
4.2.5 Nfasc140 is highly concentrated in the developing cerebellum 
Western blot of mouse brain lysates suggested the expression level of Nfasc140 is 
very high in brains of murine embryos (Fig 27). To check where the Nfasc140 
localizes in the whole brain, sagittal sections were stained with pan-Neurofascin 
antibody NFC1. MNF2 antibody can recognize Nfasc186 only, to distinguish 
Nfasc140 from Nfasc186 also MNF2 antibody were also used. Cerebellums of 
embryonic brains were found to have strong NFC1 signal also little MNF2 signal 
(Fig. 30). Hence, I focused my study on wild type animal cerebellum to check the 
possible function of Nfasc140. Immunofluorescence pictures of brain sections of 
animals showed at all ages, E13.5, E15.5 and E17. 5, NFC1 signals were detectable 
(Fig. 29). At the age of E15.5 the NFC1 signal is very strong, and the strongest 
NFC1 signal comes from the DCN of the cerebellum. Because studies on the 
developing cerebellum often on cellular migration, cell migration was examined by 
immunofluorescence studies. Results showed no obvious effects of Nfasc140 on 
cellular migration were found in the cerebellum. And also because the Nfasc186 
isoform start to express at between E13.3 and E15.5 (Fig. 24), it becomes hard to 
dissect the effect of Nfasc140 at a later age. To better understand the role of 
Nfasc140 alone, I was planning to compare the Neurofascin knockout animal with 
the transgenic animals (T140/Nfasc
-/-
) which expressing Nfasc140 only. However, I 
did not have enough time to conduct this experiment during my study, because I 





4.2.6 Nfasc140-flag can organise the nodal complex  
When the Neurofascins are deleted from the nodes, neuronal proteins like AnkyrinG, 
NrCAM and βIV-Spectrin are no longer targeted to the nodes (Sherman et al., 2005, 
Zonta et al., 2008). Conditional deletion of Neurofascins in glial or neuronal cells 
revealed that Nfasc140 is expressed in neurons. This led me to study the role of 
Nfasc140 during nodal formation and also compare the other neuronal Nfasc186 with 
Nfasc140. The results showed that Nfasc140 alone, like Nfasc186, can recruit the 
nodal proteins to the nodes of Ranvier. Also the Gliomedin and Brevican which were 
suggested to interact with Nfasc186 are also found to be targeted at the node of 
Ranvier (Fig. 38). 
 
Compared with Nfasc186, the domain composition of Nfasc140 lacks the Mucin and 
FnIIIE domains (Fig. 21). But in my study I have shown that both Nfasc140 and 
Nfasc186 can target Nav to the node of Ranvier (Fig. 38 and 39). This indicates the 
Mucin and FnIIIE domains are not necessary for Nav clustering. It is interesting that 
in nerves both Nfasc140 and Nfasc186 are expressed and have the same role of 
clustering Nav. This suggests Nfasc140 is a second neuronal Neurofascin, in addition 
to Nfasc186, with a role in the formation of nodes of Ranvier. Because the Nav 
clustering at the nodes is the foundation of the action potential propagation, it is 
possible animals evolved this two proteins having the same role to make the Nav 
clustering mechanism more stable and reliable. 
 
4.2.7 Expression of Nfasc140-flag or Nfasc186-flag partially restores nerve 
function 
In the study of Sherman et al. (2005), it was shown that total Neurofascin knockout 
mice have a reduction of peripheral nerve conduction velocity to less than 20% of 
WT mice (Fig. 39 left). Meanwhile, my electrophysiological study showed that, in 
mice only expressing Nfasc140 or Nfasc186, peripheral nerve conduction velocity is 
reduced to almost half of the WT animals, which, in both cases, is higher than the 




myelination profile of the peripheral nerves of these transgenic animals and no 
difference was found between them and WT mice. Which includes normal 
myelination in semithin cross sections of quadriceps nerves and no statistical 
difference between internodal distance. Also in previous studies of Neurofascin, 
there is no evidence that the Neurofascin will affect the nerve size. So there are two 
possible explanations for the decreased conduction velocity. First the Nav is not 
targeted very well at some of the nodes in the transgenic mice. The Nav might have 
decreased concentration at the nodes, this could slow down the depolarization and 
take more time for the active nodes to reach threshold potential. To clarify this, a 
statistical study of the intensity and size of Nav can be conducted. Second, the loss of 
Nfasc155 in these animals means the lack of the paranodal complex. This will lead to 
the loss of the physical connection between glial cells and axons at the paranodes. 
Hence a higher threshold potential is needed to activate the following nodes of 
Ranvier. In both cases I think the threshold potential will be hard to reach. So the 
active node will need more time to get enough depolarization before the action 
potential travels to the next node of Ranvier. 
 
4.2.8 Possible reasons for the behavioral abnormalities of mouse lines, 
T140/Nfasc-/- and T186/Nfasc-/- 




, show signs of 
abnormalities such as tremor and weak hindlimbs, and the motor coordination test 
confirmed those animals are abnormal in a motor behaviour test. My study is mainly 
focused on the nervous system, and I know Neurofascin could have other functions 
in different organs. Hence, the real reason for the behavioral abnormality is unclear. 
But I suspect the change in the distribution of Kv and the slower nerve conduction 
velocity could contribute to the abnormality. If the Kv redistribution caused a 
prolonged time of repolarization, it could lead to a longer refractory period, and the 
nerves may miss or not transmit some of the signals through the axons. Meanwhile, 
slower nerve conduction velocity in CNS could lead to the malfunction of 
coordination center, the cerebellum. This will compromise the coordination, 




conduction of motor neurons will mean the signals from the CNS can not reach the 
muscles at the right time so the different groups of muscle can not contract at the 
pace they should; low nerve conduction of sensory neurons could affect the signals 
from all senses sending information back to CNS, which could also affect the 
coordination of movements.  
 
Interestingly, Neurofascin knockout mice die at the age of P7, however, mice over-
expressing Nfasc140 or Nfasc186 stay alive for more than 1 year, even though the 
animals have only have half of the nerve conduction velocity of WT nerves and show 
signs of abnormalities. 
 
4.2.9 Potential role of Neurofascins in health and disease. 
Nfasc140 could possibly promote neurite outgrowth because it has a similar domain 
composition as Nfasc166 which was shown to promote the neurite outgrowth 
(Kriebel et al., 2012). Also it doesn’t have the Mucin and FNIIIE domains which are 
supposed to depress the neurite outgrowth in cell culture (Pruss et al., 2009). 
Meanwhile Nfasc186 has those domains. In my study, I have shown Nfasc140 and 
Nfasc186 could be expressed by the same neurons, which suggested they may be the 
candidate proteins which can regulate the development of neurons. Also the cell may 
express these two proteins at different level in order to control the growth or 
construction of the nervous system.  
 
Antibodies specific to either Nfasc155 or Nfasc186 have been identified in patients 
with inflammatory neuropathy (Hughes et al., 2012). If the presence of neuronal 
Nfasc140 is taken into consideration, the patients which only have Nfasc186 specific 
antibodies might have a less severe abnormality, since I have found that Nfasc140 
alone is sufficient to maintain the integrity of the nodes. Nevertheless, it is possible 
that once antibodies are generated against Nfasc186, further antibodies are also 





4.3 Intact paranodal axoglial junctions cluster Nav channels 
in the absence of neuronal Neurofascins 
4.3.1 Generation of early deletion of Neuronal Neurofascins animals 
I generated a neuronal Cre-expressing line in which the Cre was expressed at an 
early age. After crossing with mice carrying Nfasc floxed alleles, Thy-Cre/Nfasc
fl/fl
 
mice were generated. In these mice, neuronal Neurofascins (Nfasc186 and Nfasc140) 
were specifically inactivated at an early development stage, and Nfasc155 continued 
to be expressed under the control of its normal promoter in myelin-forming glia. 
Western blots of WT and transgenic animals at E15 to P8 (Fig. 40) showed that the 
Nfasc186 band was reduced at E15 and became undetectable afterwards. At E15 the 
Nfasc140 is also reduced comparing with WT. Because the Nfasc140 is down 
regulated at later ages, the Nfasc140 band is not clear in control and appears 
undetectable in transgenic animals. Those observations indicated the Cre is active 
from before E15 and neuronal Neurofascins (Nfasc186 and Nfasc140) were deleted 
in CNS. Meanwhile, at P8 when Nfasc155 appeared in the WT lanes, the Nfasc155 is 
still present. But the Nfasc155 band of transgenic has less intensity, which suggested 
Nfasc155 was affected. Two possibilities could contribute to the reduction of 
Nfasc155. First, the transgenic animals were smaller in size than litter mates. This 
indicated a possible delay on development, which could lead to a low level of 
expression of Nfasc155 in nerves. Second, because the Thy-1.2 promoter was shown 
to be able to drive the expression of Cre in non-neuron tissues (Campsall et al., 2002), 
it was possible that Cre was activated in some glial cells and deleted Nfasc155.  
 
Meanwhile, in the PNS, because the nerves express low levels of Nfasc186, it is 
impossible to check the expression of Nfasc186 by western blot. Longitudinal 
sections of Quadriceps nerve were used in an immunofluorescence study to evaluate 
the deletion of neuronal Neurofascins. The results showed at P3 almost no 
Neurofascins were targeted at the nodes (Fig. 42A), the Neurofascins staining 
appeared at P6 which is mainly Nfasc155. These observations suggested that the 
neuronal Neurofascins were abolished and a delayed expression of glial Neurofascin 





Although there was reduced or delayed expression of glial Nfasc155, paranodes can 
still be detected (Fig. 41c), hence, the animals can still be used to explore the 
relationship between paranodal axoglial junctions and Nav channels. 
4.3.2 Clustering of Nav does not require neuronal Neurofascins. 
When sampling the nodes flanked by paranodes an immunofluorescence and 
statistical study at P6 showed less than 3% neuronal Neurofascin positive nodes but 
more than 80% Nav positive nodes in both PNS and CNS. The high reduction of 
neuronal Neurofascins and a high presence of Nav showed the clustering of Nav 
without neuronal Neurofascins. This supports the view that Nav channels can be 
clustered to the nodes of Ranvier by paranodal axoglial junctions only. This is 
consistent with the studies of Zonta et al. (2008) and Feinberg et al. (2010). However, 
in my study of the PNS only two animals were used. Although the difference is clear, 
data from another animal is needed to get convincing results.  
 
Some nodes only had Nfasc155 at one side, which may reflect the delayed 
expression of Nfasc155. And I noticed in my study for some of those asymmetrical 
nodes, Nav channels are also found targeted to the nodal area, next to Nfasc155 
staining. This needs detailed research and statistical studies to confirm. If this is true, 
it means when only one side of the node has the paranodal axoglial junctions, Nav 
could still cluster to the node. This would suggest that the paranodal axoglial 
junctions are not a barrier to prevent the diffusion of Nav, but actively help the 
targeting of Nav at nodes.  
 
4.3.3 Explanations behind the difference between my results and the others. 
The in vitro study of Dzhashiashvili et al.(2007) is the first paper to propose the idea 
that Nfasc155 alone is not sufficient to organize the Nav channels. In their 
experiment they used shRNA knockdown of Nfasc186 in DRG co-culture. But their 
culture system resembled the condition of when Nfasc186 is deleted after the node 




vitro system has a very different cell environment, which also can lead to anomalous 
results as well.  
 
A recent paper (Thaxton et al., 2011) came to very different conclusions concerning 
the ability of paranodes to cluster sodium channels in the absence of neuronal 
Neruofascin in either CNS or PNS. The differences between the findings of Thaxton 
(Thaxton et al, 2011) on one hand and Zonta et al (Zonta et al., 2008), Feinberg 
(Feinberg et al., 2010) and my results on the other hand, may lie in the type of 
neuronal Cre line used by Thaxton et al to eliminate neuronal Nfasc186. In the case 
of Thaxton et al, their model was a Cre/LoxP animal model like ours, but they used 
the neuron-specific promoter Neurofilament light chain (Nefl-Cre) (Leconte et al., 
1994; Schweizer et al., 2002) to drive Cre expression. Although Nefl-Cre has been 
used as an embryonic neuronal specific Cre, in their paper Nefl-Cre only deleted 20% 
of Nfasc186 at P11 suggesting that Cre was expressed either very late or very 
inefficiently. Also, in the paper of Thaxton Cre-mediated loss of Nfasc186 in the 















Figure 47. The loss of Nfasc186 is variable in different ages in the  PNS. 
Data from the paper of Thaxton et al. showed the Nefl-Cre eliminated Nfasc186 
from almost 80% of the nodes but at P11 and P14 the Nfasc186 positive node 
rose to 80% and 20% (Thaxton et al., 2011). 
 
So in their animal the later ablation or inefficient deletion of Nfasc186 means that 
before Nfasc186 ablation, the interaction of Nfasc186 with Nav had already 
happened and the nodes of Ranvier were already formed with Nfasc186. So this 
animal model in fact included the scenario of studying sodium channel clustering 
after node formation, in other words, maintenance. Interestingly, from our 
unpublished data (Desmazieres, Zonta, Zhao et al.), deletion of Nfasc186 from a 
mature node is accompanied by the mislocalization of Nav channels. Hence their 
animal model is more likely showing the deletion of Nfasc186 after Nav targeting to 
the nodes, rather than the Nav clustering without Nfasc186. This could explain why 
their observations were different from mine. 
 
4.3.4 The phenotypes changing from F3 to F6 
Unexpectedly, when we further back-crossed animals to the C57BL/6 background, 
the phenotype of the animals changed. The expression of Nfasc155 was no longer 
detectable by western blot or immunofluorescence. The Nav channels were not 
detectable anymore and the animals died at P6. These mutant animals phenocopy 
Neurofascin knockout mice (Sherman et al., 2005, Zonta et al., 2008). However, the 
mRNA level of Nfasc155 was not changed in the PNS nerves of the mutant. This 
indicates that the loss of Nfasc155 protein localized at the paranode is not a result of 




expression in F3 generation animals, this delay could become more pronounced on a 
C57BL/6 background and leads to a more extreme phenotype with fatal effects on 
the mice.  
4.4 Concluding remarks 
This work adds substantial new evidence on the role of CAMs in the formation and 
stability of nodes of Ranvier.  
 
The third isoform of Neurofascins, Nfasc140, was been studied and its characters 
were revealed. The domain composition of Nfasc140 has been identified. The pattern 
of expression of Nfasc140 is shown. Different from other Neurofascins, Nfasc140 is 
the predominate isoform in early embryonic stage, which suggested the importance 
of Nfasc140 during the nervous system development. 
 
Nfasc140 is the only isoform of Neurofascins which has different post-translational 
modifications at different ages and in different tissues. It is differentially 
glycosylated in different part of the brain. These indicate it could have different roles 
at different development stage of animals and also in different part of the brain at the 
same age.  
 
Expressing only Nfasc140-flag in animals showed Nfasc140 can cluster the Nav and 
organise the other nodal components at the nodes of Ranvier. This subsequently 
forms functional nodes of Ranvier and permits rapid propagation of action potentials 
in myelinated axons. Comparing transgenic animals which express Nfasc140-flag or 
Nfasc186-flag only, suggested that Nfasc140 without the Mucin and FnIIIE has the 
same function as Nfasc186 in organising the node of Ranvier. Here, two similar 
proteins are involved in the same mechanism in nodal formation, which might 
indicate the importance of Neurofascins in the formation and maintenance of nodes 
of Ranvier. 
 
Besides the study of Nfasc140, an early neuronal Neurofascins deletion animal 




that clustering of Nav does not require neuronal Neurofascins; in another words Nav 
channels can be clustered to the nodes of Ranvier by paranodal axoglial junctions 
only. This should clarify the controversial theories about whether paranodal axoglial 
junctions have a role in sodium clustering. 
 
Because more and more research starts to focus on the Neurofascins and other nodal 
protein during neurological diseases, I think my study can lay down our basic 
understanding of the formation and maintenance of nodes of Ranvier. This can help 
us and other researchers to analysis the changes of proteins which are associated with 







5. Future directions 
5.1 Characterization of Nfasc140 
It has been shown that the expression of Nfasc155 alone can promote 
oligodendrocyte process migration in the CNS during myelination; moreover, 
Neurofascin knockout mice or mice with only Nfasc186 show a delay in 
oligodendrocyte process migration (Zonta et al., 2008). Since the expression level of 
Nfasc140 during the early postnatal period is correlated with the expression of MBP, 
it would be interesting to investigate whether Nfasc140 can affect oligodendrocyte 
process migration in vivo.  
 
In transgenic animals expressing either Nfasc140 or Nfasc186, the expression level 
of Nfasc140 and Nfasc186 is very high as judged by Western blot comparing with 
WT animals at the same age (Fig. 35). However, the intensity of immunostaining of 
Neurofascins at the AIS is relatively weak in transgenic animals. This suggested that 
there might be a possible interaction between Nfasc140 and Nfasc186 which 
stabilizes at the AIS. If Nfasc140-flag (FLAG-tagged) and Nfasc186-HA (HA tagged) 
were expressed in the same mouse it would be possible to check whether the flag 
staining at the AIS is stronger than in mice only expressing Nfasc140-flag. The two 
proteins could also be investigated for co-immunoprecipitation. 
 
Although there are major differences between avians and mammals, because 
Nfasc166 has been shown to increase the neurite outgrowth in chick, Nfasc140 might 
have a similar function. This could be investigated using cultured mouse neurons to 
check whether Nfasc140 can promote neurite outgrowth. 
 
5.2 Intact paranodal axoglial junctions cluster Nav channels 
in the absence of neuronal Neurofascins 
I generated two different founders for the Tcre line. Only one founder has been 




generation. It is still unclear whether all the changes of the phenotype of the F6 
animals are caused by the change of background of animals. Hence, if we compare 
the same founder and found the same phenotype changes, then we can confirm the 
animal background affects the phenotype of mutants. So it will be interesting to 
determine whether paranodal axoglial junctions are also missing when Nfasc186 is 
deleted using the second founder. In parallel, it will be of interest to put those 
animals back on to CBA background again (the original transgenic founders were 
CBA x C57BL/6 F1 hybrids), in order to determine if the phenotype I observed at F3 
is restored. 
 
In my study, I found that when neuronal Neurofascins were deleted from the nodes 
the expression of Nfasc155 is also affected (Fig. 37 and 38). And I proposed the idea 
that the Nfasc155 has a delayed expression time when neuronal Neurofascins are not 
present. To further study whether the loss of neuronal Neurofascins can delay the 
expression or targeting of Nfasc155, it would be interesting to check by 
immunofluorescence whether the paranodes at a later time point will appear. 
However, Tcre/Nfasc
fl/fl
 animals die at P6. Hence, DRG and Schwann cell co-
cultures of Tcre/Nfasc
fl/fl
 animals could be set up to study later stages of myelination 
in vitro. After myelination the co-cultures would be maintained for as long as 
possible to determine when Nfasc155 is expressed at later stages of myelination. 
Also, since I found that after overexpression of Nfasc186 or Nfasc140 the mice 
survive very well, even in the absence of intact paranodes. Therefore, it would be 
interesting to check by immunostaining and western blot whether transgenic 
Nfasc186 or Nfasc140 in Tcre/Nfasc
fl/fl
 mice at F6 generation regain the expression 
of the endogenous Nfasc155.  
 
Although sodiumchannels have a vital role in permitting saltatory conduction at the 
nodes of Ranvier, the precise mechanisms of how they are targeted to the nodes of 
Ranvier still require further study. If what I proposed in my study is true, that 
paranodal axoglial junctions can cluster Nav. It would be interesting to identify the 
downstream molecules which link the Nav and proteins which form paranodal 
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